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ABSTRACT
Left ventricular (LV) remodeling is nominally an adaptive process that restores
biomechanical function following myocardial injury and/or sustained alterations in loading
conditions. This remodeling can materialize as changes in myocardial geometry,
composition, and mechanical properties. When these changes fail to restore LV
biomechanical function, remodeling is termed maladaptive. It is generally accepted that
maladaptive LV remodeling underlies the progression to heart failure in various forms of
heart disease. The central hypothesis of this study is that we can leverage
echocardiographic imaging techniques to

non-invasively quantify changes

in

biomechanical function and mechanical properties in a serial manner throughout the
progression towards heart failure. The corollary to this hypothesis is that the observed
changes in function and mechanical properties can, at least in part, be attributed to a
reorganization of collagen within the extracellular matrix. Large animal models of
myocardial infarction and left ventricular pressure overload were integrated with
echocardiographic imaging, computational modeling, and multi-photon microscopy to test
this hypothesis. We posit that this delineation of disease-specific LV remodeling outcomes,
with focus on regional mechanical changes throughout the myocardium, will promote
translational strategies that can interrupt this deterministic process.
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CHAPTER 1
INTRODUCTION – MECHANOBIOLOGY OF THE HEART
1.1

BASIC ANATOMY AND PHYSIOLOGY
The heart, a muscular organ located in the center of the thoracic cavity, will beat

up to 10,000 times in a single day or three billion times over the average lifespan of a
human. The primary function of the heart is to serve as the pump in the cardiovascular
system which is responsible for delivering oxygen-rich blood and nutrients to every cell in
the body via the vascular network of arteries and veins. This circulation of blood is vital to
sustaining life.
1.1.1 The Four Chambers of the Heart
The internal anatomy of the heart reveals four chambers composed of cardiac
muscle (Figure 1.1). The four chambers of the heart are separated into two halves by a
central wall, the septum. Each half of the heart functions as an independent pump that
consists of an atrium and a ventricle. The atria receive incoming blood from the venous
system and the ventricles propel the blood through the arterial system in a continuous loop
(Figure 1.2). The key function of the right side of the heart is to receive unoxygenated
blood from the entire body and deliver it through the pulmonary circulatory system to the
lungs for oxygenation. Once the oxygenated blood returns to the heart through the left
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atrium, it is then actively pumped through to the entire body via the mechanical force
resulting from the contraction of the left ventricular myocardium.
The major blood vessels emerge from the base of the heart. The inferior and
superior vena cava terminate at the right atrium to return blood to the heart from the rest of
the body. The pulmonary trunk, or pulmonary artery, delivers blood to the lungs from the
right ventricle. Oxygenated blood returns to the heart from the lungs via the pulmonary
vein at the left atrium. Finally, blood is delivered from the left ventricle to the rest of the
body first through the ascending aorta. Superficially on the surface of each of the ventricles
is a network of coronary arteries and veins which supply blood to and from the heart muscle
itself. The left anterior descending artery and the left circumflex artery deliver the vast
majority of the oxygenated blood to the left ventricular myocardium so as to ensure it can
function properly as a pump.
The flow of blood through the heart is unidirectional. This is made possible by two
sets of valves which prevent the backward flow of blood. Between each atrium and
ventricle is an atrioventricular valve. These thin flaps of tissue are attached to the base of
the atrioventricular union by a ring of connective tissue. The ends of the valves on the
ventricular side are attached to collagenous tendons, the chordae tendineae. These chordae
tendineae terminate inside the ventricles at a muscle mass called the papillary muscle.
While this papillary muscle plays no role in the opening of the valves, its primary function
is to stabilize the valves and prevent inversion during ventricular contraction. While similar
in function, the two atrioventricular valves are not identical. The valve separating the right
atrium and right ventricle is called the tricuspid valve in reference to its three distinct flaps.
Alternatively, the atrioventricular valve separating the left atrium and left ventricle only
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has two flaps and is accordingly called the bicuspid valve. This bicuspid valve is more
commonly referred to as the mitral valve in reference to its resemblance to the tall
headdress worn by bishops and senior clergy, a miter. Distal to each of the two ventricles
is a semilunar valve preventing the backflow of blood from the arteries to the ventricles.
Each semilunar valve has three cuplike leaflets which snap closed when the pressure inside
of the ventricle drops during ventricular relaxation.
1.1.2 Composition of the Heart
The heart is encased in a tough membranous sac known as the pericardium. The
pericardium is attached to the diaphragm and is filled with pericardial fluid that protects
the heart and functions similarly to a lubricant. Additionally, this pericardial sac limits the
rigid body motion of the heart. The outermost layer of the heart itself is primarily composed
of collagenous matrix with some embedded elastic fibers. A cross-section of the heart
reveals that there are two additional layers, the middle myocardium and a deep lining called
the endocardium. The endocardium is a thin sheet of epithelium that lines the heart and
constitutes the valves of the heart. On the other hand, contractile cardiac myocytes make
up the bulk of the myocardium and are generally 120 µm long and 20-30 µm in diameter.
These cardiac myocytes are arranged in a locally parallel manner and are embedded in an
extracellular matrix consisting primarily of collagen. While relatively parallel on a local
level, the myocytes are arranged in a spiraled helix that varies transmurally from the
endocardium to the epicardium such that the cardiac myocytes can generate sufficient force
to direct the proper flow of blood through the cardiovascular system.

3

1.1.3 Contraction of the Heart
Much like skeletal muscle, cardiac muscle is excitable and can generate an action
potential. Unlike an innervated skeletal muscle, however, the signal for contraction is
generated by specialized non-contractile cardiac cells called autorhythmic cells. These
autorhythmic cells are commonly referred to as the pacemaker cells. These autorhythmic
cells have an unstable membrane potential which begins at -60 mV and gradually becomes
less negative until it reaches a threshold and ultimately triggers an action potential. This
action potential, originated by the pacemaker cells in the sinoatrial and atrioventricular
nodes, is conducted to the contractile cardiac myocytes. This electrical signal is then
converted to a mechanical response (i.e. contraction of the muscle) through a process called
excitation-contraction coupling. In this process, calcium ions from the sarcoplasmic
reticulum and the extracellular fluid are released and then bind to troponin – thereby
initiating the formation of actin-myosin cross-bridges and the contraction of the cell
1.1.4 The Cardiac Cycle
The cardiac cycle is the sequence of rhythmic events including the contraction and
relaxation of each of the four chambers of the heart to pump blood through the
cardiovascular system. The beginning of the cardiac cycle is commonly marked with the
brief moment at which all four chambers are relaxing. In this moment, the atria are filling
with blood from the veins. Meanwhile, active ventricular ejection has just been completed.
Subsequently, the atrioventricular valves open and blood is passively transferred to the
ventricles down the hydrostatic pressure gradient with the assistance of gravity. The final
twenty percent of ventricular filling is accomplished as the atria contract and forcibly eject
into the ventricles. Ventricular systole then begins and the rapid elevation in pressure
4

pushes against the underside of the atrioventricular valves and forces them closed so that
blood does not flow back in the atria. With both the atrioventricular and semilunar valves
closed, the cardiomyocytes of the left ventricle continue to contract in what is referred to
as isovolumic ventricular contraction. Subsequently, the resultant generation of pressure
forces the semilunar valves to open and the blood is pushed in to the arteries. This is
referred to as ventricular ejection. The force generated by this ventricular contraction
becomes the driving force for blood flow. The high-pressure blood forced in to the arteries
then displaces the stagnant low-pressure blood and forces that blood further into the
vasculature. At the end of ventricular ejection, the ventricles begin to relax, and
intraventricular pressure is reduced. Once the pressure in the arteries exceeds that of the
ventricle, the semilunar valves are forced shut by the backflow of blood from the arteries.
While the ventricles relax and the intraventricular pressure continues to fall, isovolumic
ventricular relaxation occurs. Once the atrial pressure exceeds that of the ventricle, the
atrioventricular valves open and initiate the beginning of the next cardiac cycle. This
process is summarized in the widely-accepted Wigger’s Diagram (Figure 1.3) which
illustrates the coordination of cardiac events and the resultant relationships between
hydrostatic pressure, chamber volumes, and electrical impulses. The entire cardiac cycle is
customarily simplified into two distinct phases: systole and diastole. In the left ventricle,
the onset of systole is conventionally defined as the time of the mitral valve closure or the
by the peak of the QRS complex (i.e. R) on the electrocardiographic signal. The end of
systole and the subsequent onset of diastole is conventionally defined as the end of
ventricular ejection. Finally, diastole is used to define the entire ventricular filling phase.
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1.2

CLINICAL EVALUATION OF HEART STRUCTURE AND FUNCTION
Given the vital importance of the function of the heart to sustaining life, there is an

obvious need for techniques that allow for the measurement of the myriad of geometric
and functional parameters of the heart in a clinical setting. Advancements in both hardware
and software over the years have given rise to a variety of clinically-translatable modalities
for this very purpose.
1.2.1 Echocardiography
At present, echocardiography is the most clinically-accessible modality to assess
the structure and function of the heart.1 In short, echocardiography uses ultrasonic waves,
in the order of MHz, to provide a real-time image of the beating heart. The ultrasonic beam
is produced by a transducer probe and directed towards the region of interest using a
transthoracic or transesophageal approach. As the sound waves are intersected by tissues
with varying densities, these sound waves are reflected back on the transducer. The
detected backscatter will be higher in magnitude for tissues with a higher density. The realtime processing of this backscatter on the ultrasound device allows for a non-invasive
bedside visualization of the structure and function of the heart.
Current guidelines for the clinical use of echocardiography reveal that the most
common use-case for echocardiography is for the assessment of left ventricular (LV)
systolic function and diastolic function.2 The most commonly reported quantitative
measure of global LV systolic function is the ejection fraction (EF) defined as
𝐸𝐹 =

𝑉𝐸𝐷 −𝑉𝐸𝑆
𝑉𝐸𝐷

× 100%.
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(1.1)

This measurement of EF is reliant on the measurements of LV volumes at end diastole
(𝑉𝐸𝐷 ) and end systole (𝑉𝐸𝑆 ) determined most commonly from Simpson’s biplane method
of disks.3 Along with LV EF and volumes, echocardiography also allows for the
quantification of LV internal diameters and wall thicknesses. These measurements give
rise to an estimation of LV mass originally proposed by Devereux et al in 1986 of the form
𝐿𝑉 𝑚𝑎𝑠𝑠 = 0.8{1.04[([𝐿𝑉𝐸𝐷𝐷 + 𝐼𝑉𝑆𝑑 + 𝑃𝑊𝑑]3 − 𝐿𝑉𝐸𝐷𝐷3 )]} + 0.6, (1.2)
where LVEDD, IVSd, and PWd represent LV, intraventricular septal, and posterior wall
thickness at end diastole, respectively.4
Going beyond measures of structure and function derived from geometric
measurements, Doppler principles have been applied to echocardiographic analysis to
allow for quantitative measurements of the hemodynamics in the heart to evaluate global
diastolic function.5 The phenomena first observed by Doppler in the 19th century was that
the frequency of a wave can be altered by a moving target acting as interference. In regard
to its applicability to cardiac evaluation, the ultrasonic waves emitted by the
echocardiographic probe are altered by the movement of red blood cells in such a way that
we can derive a complete picture of the cardiac flow field from an analysis of the detected
backscatter. Furthermore, the emitted frequency can be tuned for different applications. A
pulse-wave Doppler analysis has a high spatial resolution but encounters error when
measuring high-velocity flow. Meanwhile, continuous-wave Doppler excels at accurately
detecting high-velocity flow, but only flow in the direct line of the emitted signal.6 While
most commonly applied to fluid analysis, the same principles can also be applied to
structural analysis where the tissue serves as the interference for the frequency rather than
the red blood cells. Through a combinatorial approach of both fluid Doppler and tissue
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Doppler, we can measure mean pulmonary capillary wedge pressure (PCWP), an indirect
estimate of LV diastolic pressure, using the techniques first proposed by Nagueh et al in
1997 of the form
𝐸

𝑃𝐶𝑊𝑃 = 1.91 + 1.24 × 𝐸 , (1.3)
𝑎

where 𝐸 is the peak transmitral flow velocity of early left ventricular filling and 𝐸𝑎 is the
velocity of the movement of the mitral annulus at the lateral site early in diastole.
The most recent advancement to be applied to echocardiographic analysis of the
heart is that of strain imaging through speckle tracking echocardiography (STE). An early
study by Leitman et al in 2004 laid the groundwork for this technology with the initial
observation that intrinsic acoustic markers in the myocardium, or speckles, visible in
echocardiographic images were stable throughout the cardiac cycle.7 With this observation,
a tracking algorithm was developed to track the movement of the spatial mesh of acoustic
markers throughout the cardiac cycle to allow for an accurate measurement of strain in the
myocardium. Measurements of segmental strain (ε) are calculated as
𝜀=

𝐿−𝐿0
𝐿0

=

∆𝐿
𝐿0

,

(1.4)

where 𝐿 is the length of a particular myocardial segment and 𝐿0 is the length of that segment
at end diastole. Over the years, this quantitative technique has been applied with increasing
regularity for both global and regional analysis of left ventricular function and mechanical
behavior.8 The utilization of different echocardiographic views makes it possible to
determine the full field of LV strain in the circumferential, longitudinal, and radial
directions.
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1.2.2 Cardiac Magnetic Resonance Imaging
While echocardiographic analysis is certainly more clinically-accessible, the longheralded gold standard for the evaluation of cardiac structure and function is cardiac
magnet resonance imaging (cMRI). The most prominent advantage that cMRI has over
echocardiography is that it is not limited to acoustic windows. The quality of an
echocardiographic image varies greatly depending on factors such as anatomical
interference (e.g. the location of the lungs) or the degree of obesity of an individual patient.
The magnetic field applied in cMRI applications can penetrate through these interferences
and capture the entirety of the heart. Furthermore, the application of techniques such as
cMRI tagging allows for high-fidelity measurements of deformation throughout the
heart.9,10 Nevertheless, the high cost and long examinations times has severely limited the
clinical use of cMRI for the assessment of cardiac structure and function.11

1.3

MECHANICAL ASSESSMENT OF THE HEART
Under normal and pathological conditions, the function of the heart is governed and

regulated by the underlying mechanics of both the structure and the myocardium. Broadly
speaking, mechanics refers to the relationship between the forces applied to an object and
the translation, rotation, and deformation resulting from these applied forces. In the living
heart, the total mechanical behavior would be defined as the sum of both the active
mechanics resulting from the contractile cardiac myocyte and the passive mechanics of the
completely relaxed myocardium. While there is interrelation between these two forces, for
the purposes of this review, we focus only on the passive mechanics of the myocardium.
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An understanding of the relationship between the passive mechanical properties of the
heart and their effect on function is the central goal of cardiac mechanics research.
1.3.1 Benchtop (ex-vivo) Analysis
The majority of the early work characterizing the mechanics of the passive
myocardium came from uniaxial tests on excised pieces of cardiac tissue.12,13 Despite the
significance of this early work, further investigation into the locally heterogeneous
structure of the myocardium gave rise to a need to move beyond an assumption of isotropic
behavior. To that end, studies using biaxial test setups would later show that the passive
myocardium exhibits an anisotropic behavior that varies from region to region.14 This work
gave rise to a “golden-era” of cardiac mechanics research from 1980-2000 where a number
of constitutive models were developed to link the states of stress and strain in the passive
myocardium.15–20 Further work was completed by Zile and colleagues to isolate the cardiac
myocyte and perform tensile testing and eventually define constitutive relations for the
isolated myocyte. While there is clear value in these monumental studies, no one
experiment is comprehensive. It must be considered that the excision of these tissues
influences hormonal factors and control of the nervous system and ultimately the properties
of the cardiac myocytes, the myocardium, and the heart as a whole.
1.3.2 Clinical (in-vivo) Analysis
Technological advancements over the last few decades have made it possible to
perform mechanical analysis for clinical research. One of the most important advancements
in that time was the advent of sensitive cardiac catheters for the measurement of
intraventricular pressures. The use of these catheters along with image modalities such as
angiography or echocardiography allowed for detailed analysis of the relationship between
10

pressure and volume throughout the cardiac cycle. Early work by Mirsky and
Pasipoularides laid the foundation for this work.21,22 They first introduced the concept of
calculating an index of LV chamber stiffness of the form
𝑃 = 𝑃0 𝑒

𝐾𝐶

𝑉
𝑉𝑊

, (1.5)

where 𝑃 is the intraventricular pressure, 𝑃0 is a fitting parameter, 𝐾𝐶 is the chamber
stiffness, 𝑉 is the volume of the ventricular chamber, and 𝑉𝑊 is the volume of the wall.
This measurement of chamber stiffness, a structural index that is a function of geometry
and local material properties, has proven to be a valuable index of diastolic function.23 On
a local level, Janz introduced a method by which to quantify local myocardial wall stress
𝜎=

𝑃𝑟 2
2𝑡(𝑠𝑖𝑛𝜃)(𝑟+

, (1.6)

𝑡(𝑠𝑖𝑛𝜃)
)
2

where 𝑃 is the intraventricular pressure, 𝑟 is the local radius, 𝑡 is the local thickness, and 𝜃
is angle between the normal vector from the endocardium at the region of interest and the
axis of revolution in the truncated ellipsoid model.24 Since then, the major push in the invivo analysis of cardiac mechanics has come by way of advanced finite element analysis.
The work by Costa, Wenk, and others of the normal and diseased heart serves as
demonstration that detailed biomechanical analysis using computational tools is feasible,
albeit at the cost of computational time, the need for expert analysis, and expensive
hardware resources.25–29 There is a clear need for this type of technology to be made more
clinically accessible and practical for the routine analysis of cardiac mechanical function.
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1.4

HEART FAILURE – ONE SYNDROME WITH MULTIPLE ETIOLOGIES

1.4.1 Clinical Relevance
An all-too-common pathway for a host of cardiac disorders is a progression towards
heart failure. Heart failure is a complex clinical syndrome that can result from any
structural or functional cardiac disorder that impairs the ability of the ventricle to fill with
or eject blood. The rate and incidence of the development and progression of heart failure
continues to escalate, and recent statistics have identified this disease as the leading cause
of morbidity and mortality – eclipsing all other chronic diseases.30 While significant
progress has been achieved in the therapeutic management of other major illnesses such as
cancer, these advancements have not been forthcoming for heart failure. One likely reason
for this is that, unlike cancer which is classified by morphology, cell type, and
molecular/genetic profiles, heart failure has been historically considered as a single entity.
However, it has become recognized that distinctly different etiologies for the presentation
of these heart failure symptoms exist, which, in turn, have demonstrated distinctly different
therapeutic responses and clinical outcomes.31 A recent consensus has emerged that a
generalized dichotomy can be made for the classification of heart failure through the
evaluation of LV EF.32 Specifically, heart failure patients presenting with a LV EF below
45% would be classified as heart failure with reduced ejection fraction (HFrEF).
Alternatively, those heart failure patients with a normal LV EF (i.e. greater than 45%)
would be classified as heart failure with preserved ejection fraction (HFpEF). It has been
found that the prevalence of these two phenotypes of heart failure is equally distributed. 31
Furthermore, long-term morbidity and mortality rates between the two phenotypes are
virtually indistinguishable.33 Ultimately, these trends warrant further investigation so as to
12

delineate the pathophysiological mechanisms which give rise to each phenotype of heart
failure (Table 1.1). Though the progression to heart failure is unequivocally multi-factorial
in nature, the changes associated with both types of heart failure can be attributed to the
cumulative alterations in geometry, composition, and function; defined as remodeling.
1.4.2 Systolic Heart Failure (HFrEF)
Systolic heart failure, commonly referred to as HFrEF, is a clinical syndrome
characterized by a dilation of the left ventricle and impaired systolic pump function. HFrEF
is an all-too-common sequela of myocardial infarction (MI). A MI occurs secondary to an
acute coronary event which functionally cuts off the flow of oxygen-rich blood to the area
of the myocardium supplied by that vessel. This local ischemia results in cardiac myocyte
death and the development of a non-viable and fibrotic scar.34 In the days and weeks that
follow this acute event, there are progressive changes in the LV geometry on a global (e.g.
increased end-diastolic volume) and local (e.g. thinning within the MI region and
hypertrophy of the viable remote region) scale.35–41 Critically, these structural
abnormalities have a detrimental effect on the systolic function of the LV. This systolic
dysfunction becomes apparent through an analysis of LV EF as it commonly falls below
45%.42 This fall in EF can be attributed to several factors such as severe dilation of the LV,
a high prevalence of non-viable myocardium, and changes in the passive mechanical
properties of both the MI region and the remote myocardium.41,43,44 Ultimately, the
inability to meet the metabolic demands of the body through normal pump function gives
rise to the presentation of the signs and symptoms of HFrEF.
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1.4.3 Diastolic Heart Failure (HFpEF)
Diastolic heart failure, commonly referred to as HFpEF, is a clinical syndrome
characterized by a presentation of the signs and symptoms of heart failure, abnormal
diastolic function, and a preserved ejection fraction. Conceptually, HFpEF occurs when
the LV chamber compliance is reduced to the point at which it can no longer accept an
adequate volume of blood during the diastolic filling phase. This type of heart failure
commonly results from an exposure to a prolonged LV pressure overload such as aortic
stenosis.45 HFpEF that occurs secondary to LV pressure overload results in a thick,
hypertrophied, left ventricle. Furthermore, this disease is coincident with the presentation
of abnormal active relaxation. This phenomena becomes apparent through the
echocardiographic observation of either a prolonged isovolumic relaxation phase or
delayed active relaxation.46 In addition to active relaxation, the passive mechanical
properties of the LV myocardium contribute to this presentation of diastolic dysfunction.
On a structural/chamber level, this is made evident by elevations in chamber stiffness (KC)
determined from end diastolic pressure-volume relations.3,47,48 On a local material level,
the determination of regional myocardial stiffness (KM) from stress-strain or stressdiameter relationships reveals increases in the passive stiffness of the cardiac myocyte and
the extracellular matrix it is embedded within.42,49 Coupled together, abnormal relaxation
and increases in stiffness ultimately initiate a cascade of events including elevations in LV
filling pressures, dilation of the left atrium, and a presentation of the signs and symptoms
of HFpEF.50,51
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1.5

DISSERTATION SCOPE AND SPECIFIC AIMS
The primary goal of this dissertation is to advance the state of knowledge in the

field in regard to pathophysiological mechanisms which give rise to heart failure and how
they interrelate with local changes in mechanical behavior and mechanical properties as a
consequence of disease-induced remodeling. The central hypothesis of this study is that we
can leverage echocardiographic imaging techniques to non-invasively quantify changes in
biomechanical function and mechanical properties in a serial manner throughout the
progression towards heart failure. The corollary to this hypothesis is that the observed
changes in function and mechanical properties can, at least in part, be attributed to a
reorganization of collagen within the extracellular matrix. This hypothesis was tested with
a combinatorial approach of clinically-relevant large animal models of heart failure, novel
image-processing techniques, and computational modeling. These results provide novel
information on LV remodeling outcomes in clinically-relevant disease states and lay the
groundwork for the evaluation of emergent therapeutic strategies that seek to curtail
adverse remodeling.
1.5.1 Aim 1 – Quantify regional and temporal changes in left ventricular strain and
stiffness in a porcine model of myocardial infarction
For the first time, STE was used to serially track regional biomechanical behavior
and mechanical properties post-MI. We found that changes initially confined to the MI
region extended throughout the myocardium in a non-uniform fashion over 28 days postMI. We posit that STE-based evaluation of regional changes in LV biomechanics could
advance both clinical assessment of left ventricular remodeling and therapeutic strategies
that target aberrant biomechanical behavior post-MI.
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1.5.2 Aim 2 – Quantify changes in myocardial microstructure and mechanics secondary
to left ventricular pressure overload
Left ventricular pressure overload has been shown to give rise to the HFpEF
phenotype. LVPO was induced in mature pigs by inflation of an implanted ascending aortic
cuff for up to five weeks. Serial echocardiographic analyses of diastolic function and
mechanical properties along with terminal histological analysis allowed for a correlative
analysis of the abnormalities in the microstructural composition of the extracellular matrix
and these observed changes in structure and function. Our findings support the use of serial
biomechanical analysis to track the progression of HFpEF and present a translational
method to stratify patient-specific risk and assess the efficacy of pharmacological and
therapeutic approaches.
1.5.3 Aim 3 – Develop a clinically-accessible tool for the identification of the passive
mechanical properties of the left ventricular myocardium
Sensitive techniques to track the rate and extent of remodeling are necessary to
evaluate risk and treatment options on a patient-specific basis throughout the progression
to heart failure. The technology we have developed is a novel and non-obvious extension
of two-dimensional STE which allows for the definition of a constitutive relation for the
regional left ventricular myocardium that links the states of stress and strain. This was
accomplished through the use of an inverse finite element analysis approach along with a
novel objective function which accounts for regional differences in strain and thickness.
This technology allows for a comprehensive biomechanical analysis of the left ventricle to
be performed in a clinical setting for the assessment of the rate and extent of myocardial
remodeling in response to heart disease.
16

1.6

TABLES
Table 1.1: Features that differentiate HFrEF from HFpEF.
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1.7

FIGURES
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Figure 1.1: Anatomy of the heart and major blood vessels.
There are four main chambers to the heart: right atrium, right ventricle, left atrium, and
left ventricle. The atria and ventricles are separated by atrioventricular valves and the
semilunar valves prevent backflow of blood from the major arteries to the ventricles.
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Figure 1.2: Cardiovascular circulation.
Blood collected in the right atrium is pumped into the right ventricle. Contraction of the
right ventricle sends the blood through the pulmonary system for oxygenation. After
oxygenation, the blood returns to the heart through the left atrium. Blood then goes to
the left ventricle where the force is generated to pump the blood through the rest of the
body.
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Figure 1.3: Wigger’s Diagram.
This diagram is a representation of the electrical and mechanical events of the cardiac
cycle. By DanielChangMD, revised original work of DestinyQx, redrawn as SVG by
xavax (Wikimedia Commons, File: Wiggers_Diagram.svg), “Wigger’s Diagram”,
https://creativecommons.org/licenses/by-sa/2.5/legalcode
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CHAPTER 2
REGIONAL AND TEMPORAL CHANGES IN LEFT VENTRICULAR
STRAIN AND STIFFNESS IN A PORCINE MODEL OF
MYOCARDIAL INFARCTION

1

1

Torres W. M., Jacobs J., Doviak, H., Barlow S. C., Zile M. R., Shazly T., Spinale F. G.
2018. Regional and temporal changes in left ventricular strain and stiffness in a porcine
model of myocardial infarction. American Journal of Physiology – Heart and Circulatory
Physiology. 315(4): H958-H967. Reprinted here with permission of publisher.
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2.1

ABSTRACT
The aim of this study was to serially track how myocardial infarction (MI) impacts

regional myocardial strain and mechanical properties of the left ventricle (LV) in a large
animal model. Post-MI remodeling has distinct regional effects throughout the LV
myocardium. Regional quantification of LV biomechanical behavior could help explain
changes in global function and thus advance clinical assessment of post-MI remodeling.
The present study is based on a porcine MI model to characterize LV biomechanics over
28 days post-MI via speckle-tracking echocardiography (STE). Regional myocardial strain
and strain rate were recorded in the circumferential, radial, and longitudinal directions at
baseline and at three, 14, and 28 days post-MI. Regional myocardial wall stress was
calculated using standard echocardiographic metrics of geometry and Doppler-derived
hemodynamic measurements. Regional diastolic myocardial stiffness was calculated from
the resultant stress-strain relations. Peak strain and phasic strain rates were nonuniformly
reduced throughout the myocardium post-MI, while time to peak strain was increased to a
similar degree in the MI region and border zone by 28 days post-MI. Elevations in diastolic
myocardial stiffness in the MI region plateaued at 14 days post-MI, after which a
significant reduction in MI regional stiffness in the longitudinal direction occurred between
14 and 28 days post-MI. Post-MI biomechanical changes in the LV myocardium were
initially limited to the MI region but nonuniformly extended into the neighboring border
zone and remote myocardium over 28 days post-MI. STE enabled quantification of
regional and temporal differences in myocardial strain and diastolic stiffness, underscoring
the potential of this technique for clinical assessment of post-MI remodeling.
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2.2

INTRODUCTION
The post-MI period is accompanied by temporal changes in inflammatory-

signaling-proteolytic cascades within the MI region, which in turn give rise to changes in
LV geometry, composition, and function in a process termed post-MI remodeling

52,53

.

Global changes in LV geometry (e.g., increased EDV) and pump function (e.g., reduced
EF) are commonly used to assess the relative extent of post-MI remodeling 54–56. However,
this is a spatially nonuniform process, as myocardial thinning (within the MI region) occurs
concomitantly with hypertrophy (within the viable remote region) 35,36. As such, improved
regional assessment of temporal changes throughout the myocardium may enhance clinical
evaluation of the rate and extent of the post-MI remodeling process.
In vivo regional mechanical behavior has been assessed post-MI in both basic
scientific and clinical studies using techniques such as sonomicrometry, cardiac magnetic
resonance imaging, and tissue Doppler-derived imaging

57–63

. While these and other

approaches have yielded critical information on the post-MI remodeling process, they have
not been uniformly applied to assess LV regional function across the entire chamber and
in a serial fashion due to several factors. In large animal studies using sonomicrometry,
high spatial and temporal resolution is offset by a limited field of view

58,59

. In clinical

studies, noninvasive approaches such as cardiac magnetic resonance imaging can provide
high fidelity regional assessment of LV function, but lengthy acquisition and postprocessing times make it impractical to collect repeated measurements 60. Tissue Dopplerderived imaging has also been applied in both large animal models and clinical settings to
quantify regional myocardial strain with reported limitations stemming from a significant
dependency on the angle of the ultrasound beam and low signal-to-noise ratio 61–63.
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STE, an ultrasound-based technique which tracks the movement of intrinsic
acoustic markers of the LV, has the potential to address limitations of tissue Doppler
approaches. Past large animal and clinical studies have demonstrated the feasibility of STE
in terms of post-MI assessment of LV regional function

64–72

. It has been established that

longitudinal strain patterns can be used to identify regions of ischemic injury and predict
remodeling outcomes

64,65

. Measures of global radial and circumferential strains have

shown correlation with MI size and can enable differentiation between subendocardial and
transmural infarction 67–69. STE can also capture the heterogeneous and temporal changes
in LV strain in the minutes immediately after MI and over more extensive time intervals
post-MI 70–72. Despite these advancements, there is a paucity of studies that have applied
STE to serially assess the extent and magnitude of changes in regional strain over the
critical early remodeling period (up to 28 days post-MI) in a large animal model.
Furthermore, no studies to date have extended STE to track regional mechanical property
changes post-MI. The current study utilizes a porcine model of an acute coronary syndrome
and subsequent MI based on an intracoronary IR approach; STE is then performed up to
28 days post-MI. We postulate that this combinatorial approach to the in-vivo
quantification of LV mechanical behavior post-MI will yield novel insight into the
progression of the post-MI remodeling process and thereby motivate the development of
therapeutic strategies, which aim to mitigate these adverse effects.
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2.3

METHODS

2.3.1 IR Protocol
Mature pigs (n=8) (Yorkshire, male, 22.0 ± 0.9 kg) were administered amiodarone
(200 mg PO) and aspirin (81 mg PO) for three days pre-operatively and a broad-spectrum
antibiotic (Draxxin, 2.5 mg/kg, IM) at least once pre-operatively. On the day of surgery,
the pigs were sedated (ketamine/acepromazine/atropine: 22/1.1/0.04 mg/kg IM,
respectively), intubated, and then maintained on 1.5 – 2.0 % isoflurane delivered in an
oxygen/nitrous mixture (3:1 L/min, respectively). Buprenorphine (0.05 mg/kg IM) was
administered as pre-surgery analgesia. An intravenous infusion (via ear vein cannula) of
Benadryl (25 mg) in conjunction with a continuous lidocaine infusion (4 mg/kg/hr) and
lactated ringer’s solution (10 mL/kg/hr) was initiated. The region encompassing the right
femoral artery was prepared in a sterile fashion, the main branch of the femoral artery
surgically exposed, and a catheter introducer (6F Input Introducer Sheath, Medtronic)
positioned and stabilized in the artery. A bolus of heparin was administered (4000 units,
IV) prior to placement of the guide catheter followed by an additional bolus every hour
(1000 units, IV). Under fluoroscopic guidance (GE OEC 9600, UT), a coronary
angiography catheter/launcher (5F Launcher guiding catheter .058" HSI, Medtronic) was
placed in the left coronary ostia, and an angioplasty balloon catheter containing an injection
lumen (3mm x 10mm Sprinter OTW balloon catheter, Medtronic) was positioned in the
lower portion of the left anterior descending artery (LAD; defined as 1 cm below the First
Diagonal). The LAD was occluded by balloon inflation (12 ATM balloon inflation
pressure, Everest 30 Disposable inflation device, Medtronic) and maintained for 90
minutes. The balloon was then deflated, and the catheter system disengaged and removed.
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The femoral artery was ligated, and the incision closed. A transdermal fentanyl patch was
placed for three days for post-operative analgesia. Prior studies have demonstrated that this
technique produces a highly-reproducible anteroapical ischemic region resulting in an MI,
which constitutes approximately 8.7% ± 1.3% of the entire LV at 28 days post-MI 73,74.
All experimental protocols were approved by the Institutional Animal Care
and Use Committees at the University of South Carolina and performed according to the
National Institutes of Health guidelines for Care and Use of Laboratory Animals.
2.3.2 Standard Echocardiography
The day before the animals underwent the IR protocol, they were sedated
(diazepam, 200 mg PO, Barr Laboratories, Pomona, NY), placed in a custom-designed
sling, and echocardiography was performed (GE Vivid E9 with XDclear Ultrasound
System: M5S (1.5-4.6 MHz) transducer probe). Cardiac dimensions and function were
assessed by two-dimensional echocardiographic studies. The transthoracic images were
acquired from a right parasternal approach and the LV was imaged in long axis and short
axis views. The short axis views were taken at the level of the papillary muscles. EDV,
ESV, and EF were calculated using the biplane method of disks. Pulse-wave Doppler, using
a sample volume placed at the tips of the mitral valve leaflets, was used to determine the
peak early mitral inflow velocity (E). Tissue Doppler assessment was used to calculate the
peak early mitral annular velocity (E’) with a sample volume positioned at the lateral site
of the mitral annulus. PCWP was calculated using the method proposed by Nagueh et al in
1997. Additionally, wall thickness was collected at early- and end-diastole for each of the
six conventional echocardiogram LV segments in the parasternal long-axis and papillary
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level short-axis. The pigs were returned to the laboratory under identical sedation/study
conditions at three, 14, and 28 days post-MI.
2.3.3 Strain Imaging
Digital loops of the two-dimensional echocardiography for the long axis and
papillary short axis (acquired at 40 Hz) were stored on a hard disk and transferred to a
workstation (EchoPac, Vingmed, General Electric) for post-processing. For each digital
loop, a ROI was defined at the onset of the R-wave by manually identifying the endocardial
and epicardial borders. The ROI was then discretized with a spatial mesh of acoustic
clusters to be tracked on a frame-to-frame basis throughout a single cardiac cycle 7. The
end of systole was defined as the point at which the LV cross-sectional area was at a
minimum. After the semi-automated grouping of acoustic clusters in accordance with six
anatomical locations (Figure 2.1A), regional tracking quality was assessed, and the ROI
was manually adjusted by the operator to improve tracking quality where necessary.
Successful tracking of the ROI allows for the definition of segmental lengths, which are
computed at end diastole (L0) and continuously throughout the cardiac cycle (L). Local
segmental strains (ε) and strain rates (γ) are then computed as:
𝜀=

𝐿−𝐿0

𝛾=

(∆𝐿/∆𝑡)

=

𝐿0

𝐿0

∆𝐿
𝐿0

(2.1)
(2.2)

where Δt is the relative time in the cardiac cycle. Peak strain, systolic strain rate, and
diastolic strain rate were quantified in the three normal directions: circumferential
(papillary short axis), radial (papillary short axis), and longitudinal (long axis).
Circumferential and longitudinal segmental strains/strain rates were quantified at the
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epicardial, mid-myocardial, and endocardial surfaces. Global strain values were calculated
as the mean segmental strain observed in the 18 myocardial segments in the circumferential
and longitudinal directions and six segments in the radial direction. Obtained segmental
strain and strain rate data were assessed for intra-observer variance by calculating the intraclass correlation coefficient for a single operator under the assumption that systematic
differences are relevant. The intra-class correlation coefficient for all measures of strain
and strain rate ranged from 0.94 to 0.99.
2.3.4 Aggregate Regional Definitions
In this study, each pig had a total occlusion of the LAD. To facilitate data analysis,
we defined the following aggregate regions: the MI region is all anterior and anteroseptum
walls; the border zone is the apical and mid posterior, basal septal, and basal lateral walls;
the remote region is the basal posterior and inferior walls. While the size of the MI region,
and thus the size and location of the border zone, change over time post-MI, the use of
consistent regions at all study time points allows for the continuous monitoring of local
biomechanical changes throughout the myocardium.
2.3.5 Mean Wall Stresses
We modified a thick-walled ellipsoidal model proposed by Janz 24 to compute mean
wall stresses. The mean circumferential wall stress (𝜎𝐶 ) was computed as:
𝜎𝐶 =

𝑃𝑟 2
𝑡
2

2𝑡(𝑟+ )

(2.3)

where (r) is the inner radius, (t) is the wall thickness, and (P) is the LV pressure. For the
purposes of this study, (P) was assumed to equal zero at the onset on diastole and the PCWP
at end-diastole.
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The mean longitudinal wall stress (𝜎𝐿 ) was computed as:
𝜎𝐿 =

𝑃𝑟 2
2𝑡(𝑠𝑖𝑛𝜃)(𝑟+

𝑡(𝑠𝑖𝑛𝜃)
)
2

(2.4)

where (Φ) is the angle between the normal vector from the endocardium at the ROI and
the axis of revolution in the truncated ellipsoid model.
2.3.6 Regional Diastolic Myocardial Stiffness
Obtained values for mean wall stresses and segmental strains at the onset of diastole
and end-diastole enabled calculation of regional diastolic myocardial stiffness in both the
circumferential and longitudinal directions. The slope of the line between these two points
in the stress-strain plane, developed in either the circumferential or longitudinal direction
and referenced to the defined anatomical locations, was used to compute the regional
diastolic myocardial stiffness (KMR) as:
𝜎

𝜅𝑀𝑅 = |𝜀𝐸𝐷|
𝐷0

(2.5)

where 𝜎𝐸𝐷 and 𝜀𝐷0 are the end diastolic mean wall stress and segmental strain at the onset
of diastole, respectively.
2.3.7 Statistical Analysis
Data are reported as the mean ± standard error of the mean. A post hoc analysis of
baseline (pre-MI) global stiffness values with an assumption of a 30% effect and sample
size of eight yielded a statistical power of greater than 80%. The comparative analysis was
performed with either a one-way or two-way analysis of variance followed by pair-wise
comparisons using the LSD post hoc study. All statistical analyses were performed with
SPSS software (version 24.0, SPSS Inc). A p-value less than 0.05 was considered
statistically significant.
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2.4

RESULTS

2.4.1 LV Function and Geometry
Assessments of LV function and geometry at baseline and at specific post-MI time
points are shown in Table 2.1. At 28 days post-MI, LV EF fell by over 40%, LV EDV
more than doubled, and PCWP increased by 80% relative to baseline values.
2.4.2 STE-Based Strain Measurements
Representative plots of mid-myocardial segmental strains (Figure 2.1B)
demonstrate that STE provided a continuous strain measurement over the cardiac cycle at
all specified anatomical locations. As depicted by a representative LV circumferential
section, the MI region, border zone, and remote region are contained within the designated
myocardial regions at 28 days post-MI, thus supporting the aggregate definition of these
regions throughout the study (Figure 2.2). Spatial maps of peak segmental strains
qualitatively show that post-MI changes varied throughout the myocardium and exhibited
obvious directional dependence (Figure 2.3). At three days post-MI, peak global strain in
the radial and longitudinal directions decreased by approximately 40%, whereas reduction
in the circumferential direction was not significant until 28 days post-MI.
The relative time at which peak strain occurred in the MI region increased by
approximately 30%-40% with respect to baseline at three days post-MI in all directions,
with these early changes in the circumferential and longitudinal directions largely
maintained throughout the study observation period (Figure 2.4). Within the border zone,
an approximate 30% increase in the relative time to peak strain occurred at all post-MI
times in the radial direction, but significant increases in the circumferential and
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longitudinal directions were only recorded at 28 days post-MI. The remote region exhibited
the least pronounced changes, as the only significant deviations from baseline were found
in the radial direction at 28 days post-MI.
2.4.3 Phasic Strain Rates
Spatial maps of segmental strain rates show that MI impacted both phases of the
cardiac cycle and that the greatest reductions in strain rates primarily occurred within the
MI region (Figure 2.5). Reductions of over 50% in global systolic strain rate were observed
at three days post-MI in the radial and longitudinal directions but were not significant until
28 days post-MI in the circumferential direction. Global diastolic strain rates were
relatively preserved post-MI with significant reductions observed only at 14- and 28-days
post-MI in the longitudinal direction.
2.4.4 Mean Wall Stresses and Diastolic Myocardial Stiffness
End-diastolic mean wall stress monotonically increased throughout the 28-day
observation period in both the circumferential and longitudinal directions with all regional
values approximately doubling with respect to baseline by 28 days post-MI (Figure 2.6).
Spatial maps of diastolic myocardial stiffness show that mechanical heterogeneity
evidently increased post-MI (Figure 2.7A). Global diastolic myocardial stiffness
underwent a greater than three-fold elevation by 14 days post-MI in the circumferential
direction and three-fold elevation by three days post-MI in the longitudinal direction. In
the longitudinal direction, significant diastolic myocardial stiffness elevations occurred in
the MI region and border zone by three days post-MI and by 14 days post-MI in the remote
region (Figure 2.7B). All three regions exhibited significantly elevated diastolic
myocardial stiffness by 14 days post-MI in the circumferential direction. In the MI region,
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diastolic myocardial stiffness in both directions was maximal at 14 days post-MI. In the
longitudinal direction, an approximate 40% decrease in stiffness from this maximal value
occurred between 14- and 28-days post-MI.

2.5

DISCUSSION

2.5.1 Study Overview
Changes in LV geometry and function invariably occur following MI in a
multifactorial process termed post-MI remodeling

52,53

. Given the inherent spatial

nonuniformity of post-MI remodeling, approaches for quantifying LV function in a global
context can be problematic, and therefore assessment of regional biomechanics may
provide improved insight into this process. The present study addressed this issue by
serially examining LV strain and strain rates, indices of myocardial function, in defined
myocardial regions post-MI. Using a large animal model of post-MI remodeling and STEderived indices, the significant findings from this study were two-fold. First, myocardial
strain and strain rate fell within the MI region at three days post-MI, consistent with a loss
of viable myocardium and hence contractile capacity. However, while the reduction in
strain patterns was confined initially within the MI region, this reduction nonuniformly
extended into the viable LV myocardial regions over one-month post-MI. Second, when
regional myocardial diastolic stiffness was computed using local stress-strain relationships,
a biphasic change within the MI region was observed. Specifically, diastolic myocardial
stiffness initially increased within the MI region but at later post-MI time points remained
constant in the circumferential direction and significantly fell in the longitudinal direction.
Despite these regional and directional differences, diastolic myocardial stiffness was
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significantly elevated throughout the entire myocardium by 28 days post-MI. Thus, serial
assessment of regional LV function post-MI identified that time- and region-dependent
changes in myocardial mechanical properties occur over 28 days post-MI, potentially
providing more sensitive response variables when evaluating disease progression and
therapeutic interventions.
2.5.2 Previous Supportive Findings
STE-based strain measures in our study were comparable to previous large animal
and clinical studies. Specifically, our baseline global strain values fell within normal ranges
defined by a meta-analysis of over 2,500 human subjects

75

. Additionally, directional

changes in peak strain observed in the MI region, border zone, and remote region track
well with those reported in other large animal models 70,71. Our data also support previous
studies that found elevated MI region stiffness 76–79, including via sonomicrometry 58 and
three-dimensional magnetic resonance

80

. Moreover, results from planar bi-axial

mechanical testing on freshly excised square samples of remote and infarcted myocardium
showed that MI region stiffness peaked at one- to two-weeks post-MI, followed by a period
of decreasing stiffness 81.
2.5.3 Mechanistic Implications
The present study identified unique spatial, directional, and temporal variations in
regional function during post-MI remodeling, which are associated with increased
mechanical heterogeneity throughout the LV myocardium. We posit that this mechanical
heterogeneity may be the biophysical stimulus that is translated into cellular and
extracellular changes within the MI and surrounding region, ultimately contributing to MI
expansion and eventually LV failure. For example, during the first 14 days post-MI, the
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diastolic myocardial stiffness of the MI region and the neighboring border zone became
increasingly disparate, exemplified by the nearly order-of-magnitude greater MI region
stiffness in the longitudinal direction. Such abrupt spatial gradients in mechanical stiffness
that emerge between the MI and viable regions likely induce localized elevations in
myocardial wall stress and dyskinesis throughout the cardiac cycle, which in turn would
stimulate further remodeling and the progressive expansion of the MI region

82

. The

reduction in stiffness of the MI region observed at 28 days post-MI relative to 14 days postMI may facilitate the continued expansion of the MI region as evidenced by the increase
in LV EDV over that period. Furthermore, relative values of border zone/MI region
stiffness at 14- and 28-days post-MI suggest that at the terminal time point, mechanical
properties throughout the myocardium become more homogenous in both the
circumferential and longitudinal directions. Such property homogenization may, in turn,
suggest an approach to mechanical homeostasis by 28 days post-MI – commensurate with
the plateau in MI region expansion reported in previous studies

57

. Conversely, the

progressive stiffening of the hypertrophied remote region between 14 and 28 days may
play a pivotal role in driving the elevations in PCWP which may, in turn, facilitate the LV
dilation. To promote further association of regional mechanical property changes with
global LV function, we consider as an index of LV chamber stiffness the ratio between
PCWP and LV EDV. When computed using our data, this index at baseline is valued as
0.24 ± 0.04 and is found to be consistently reduced by 40% relative to baseline at 14- and
28-days post-MI. Antithetical changes in diastolic myocardial stiffness of the MI region
and remote region between 14 and 28 days post-MI may explain the relatively constant
index of LV chamber stiffness over this post-MI period. The coincidence between the
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divergence of regional changes in myocardial mechanical properties and the development
of congestive symptoms suggests that regional stiffness variations may be a key factor, and
thus therapeutic target, in heart failure progression.
These biomechanical changes are also seemingly synchronized with deterministic
biological processes that occur in and around the MI region. These changes include
fibroblast proliferation and collagen deposition – resulting in the formation of a mature
scar composed of extracellular matrix by 14 days post-MI 83. This intermediate phase of
post-MI remodeling also concurs with the highest disparity in fibrillar collagen content
between the MI region and border zone and dynamic changes in protein expression
profiles, which directly modulate the reparative response 84. Furthermore, there is evidence
that many of these regional biophysical changes are modulated by mechanosensitive
cardiac cells that sense and respond to their local mechanical environment 85. To that end,
mechanical heterogeneity that emerges post-MI represents a biophysical response variable
that can explain temporal and spatial variations in key biological processes that occur
during post-MI remodeling.
2.5.4 Therapeutic Implications
While cause and effect relationships are difficult to discern with respect to
synchronized biological versus biomechanical changes, our data support the regional
modulation of myocardial mechanical properties as a potential therapeutic target. As
suggested above, the increase in EDV from 14 to 28 days may be facilitated by a decrease
in MI region stiffness, suggesting that treatment to maintain or increase MI region stiffness
may blunt dilation. Similarly, the increase in PCWP from 14 to 28 days may be facilitated
by an increase in remote region stiffness, suggesting that treatment to decrease remote
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region stiffness may also blunt dilation. Indeed, previous studies show that biomaterials
directly injected into the MI region acutely stiffen the myocardium and effectively curtail
the adverse effects of post-MI remodeling 86,87. Regional biomechanical assessment can be
used to advance local biomaterial injection strategies, including the optimization of
biomaterial mechanical properties, total amount, and spatial distribution upon injection,
such that mechanical heterogeneity is limited in the early stages of post-MI remodeling.
This general concept is supported by previous results obtained with finite element
simulations, which predict that biomaterial injections concentrated within the border zone
(as opposed to uniformly delivered throughout the MI region) attenuate myocardial wall
stress and promote efficient pump function 88.
STE has been previously used to discriminate between infarcted and contractile
myocardium post-MI

89

. Moreover, many studies have shown the utility of quantifying

global values of STE-derived strain and strain rate with good feasibility, reproducibility,
and accuracy in clinical and large animal populations 64–72. In accordance with these prior
studies, we found significant reductions in global myocardial strain and strain rate postMI. While global strain has been extensively quantified in the post-MI context, regional
measurements in our study suggest that the initially antithetical changes in the MI and
remote regions likely weaken the sensitivity and diagnostic strength of traditional global
metrics of function. Furthermore, this study demonstrates that STE-derived myocardial
strain combined with traditional echocardiography and Doppler-derived hemodynamic
parameters can be used to compute a regional diastolic myocardial stiffness. While an
analogous technique has been applied to aortic aneurysms
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90

, we are the first to

noninvasively quantify regional diastolic stiffness using STE in the context of post-MI
remodeling.
2.5.5 Study Limitations
Several study limitations must be considered for careful interpretation of the
obtained results. Firstly, all metrics of LV function are dependent on load. To that end, the
findings from this study only account for patient-specific variance in hemodynamics
through the estimation of LV pressure at end-diastole (PCWP) and an assumption of
negligible LV pressure at the onset of diastole. Additionally, as with all echocardiographic
techniques, successful quantification of myocardial strain via STE is highly dependent on
image quality. To translate this technology into a clinical setting, one must consider that
the ability to capture echocardiographic images of sufficient quality is markedly impaired
in obese patients or patients with respiratory disorders. However, we expect that the clinical
utility of the regional tracking of segmental strains will markedly increase as the underlying
technology becomes more reproducible and reliable. Furthermore, these findings were for
an anteroapical MI location in a porcine model and thus may not hold true with different
MI locations, severity of myocardial ischemia, and/or across species. Finally,
biomechanical changes were only assessed over 28 days post-MI in our study. Although
this period has been shown to exhibit significant collagen deposition in a porcine model 91,
care must be taken when extrapolating these findings into long-term effects given evidence
that there are changes in LV strain and strain rate that continue through 1-3 months postMI 26.
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2.5.6 Conclusion
Post-MI remodeling induced progressive changes in LV biomechanics that
manifest as regional differences in myocardial strain and strain rate over 28 days post-MI.
For the first time, the utility of STE was extended in a large animal model to quantify
regional diastolic myocardial stiffness in a serial fashion post-MI. Finally, this study
identified the biphasic and at times opposing nature of regional changes in myocardial
diastolic stiffness, which in turn is a likely contributing factor for a “feed forward”
mechanism for adverse LV post-MI remodeling. Future therapeutic strategies that mitigate
this significant regional stiffness gradient between the MI and adjacent viable myocardium
may be a potential target for attenuating post-MI remodeling.
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2.7

TABLES

Table 2.1: Speckle tracking echocardiography enables quantification of
myocardial segmental strain.
Baseline

3 Days

14 Days

28 Days

EF [%]

69.1 ± 0.8

49.4 ± 2.7*

37.8 ± 2.3*†

37.5 ± 3.4*†

LV EDV [mL]

37.2 ± 1.5

59.3 ± 5.1*

77.2 ± 6.5*†

83.6 ± 6.4*†

PCWP [mmHg]

7.6 ± 0.6

9.3 ± 0.6*

12.2 ± 0.9*†

13.9 ± 1.1*†

* p<0.05 vs. Respective Baseline Value, † p<0.05 vs. Respective 3 days Value, EF: ejection fraction, LV EDV: left ventricular end
diastolic volume, PCWP: pulmonary capillary wedge pressure (n=8, one-way analysis of variance with post hoc LSD comparisons).
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2.8

FIGURES
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Figure 2.1: Speckle tracking echocardiography enables quantification of
myocardial segmental strain.
(A) Representative echocardiographic images obtained 28 days post-MI (at end
diastole) divided into six anatomical zones for speckle tracking. (B) Representative
segmental strain curves of the LV mid-wall over one cardiac cycle at 28 days post-MI
in the circumferential, radial, and longitudinal directions.
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Figure 2.2: Definition of aggregate regions based on MI location
(A) Representative LV circumferential section cut across the central portion of the MI
and stained with triphenyltetrazolium chloride shows the (B) agreement between
designated aggregate MI region, border zone, and remote region at 28 days post-MI.
The jagged line represents the edges of the MI region
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Figure 2.3: Peak myocardial strain
Spatial maps of the absolute value of peak myocardial segmental strain in the
circumferential (top row), radial (middle row), and longitudinal (bottom row) directions
at baseline and at three, 14, and 28 days post-MI. Inscribed values indicate the peak
global strain reported as the mean absolute value ± standard error of the mean. * p<0.05
vs. respective baseline value (n=8, one-way analysis of variance with post hoc LSD
comparisons).
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Figure 2.4: Relative time to peak myocardial strain
The relative time at which peak myocardial strain occurred for each region at baseline
and at three, 14, and 28 days post-MI, with relative time defined as percent completion
of one cardiac cycle; * p<0.05 vs. respective baseline value, † p<0.05 vs. respective
three days value (n=8, one-way analysis of variance with post hoc LSD comparisons).
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Figure 2.5: Phasic myocardial strain rate
Spatial maps of the absolute value of the (A) systolic and (B) diastolic myocardial
segmental strain rates in the circumferential (top rows), radial (middle rows), and
longitudinal (bottom rows) directions at baseline and at three, 14, and 28 days post-MI.
Inscribed values indicate the global strain rate reported as the mean absolute value ±
standard error of the mean. * p<0.05 vs. respective baseline value (n=8, one-way
analysis of variance with post hoc LSD comparisons).
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Figure 2.6: Stress-strain relations
Regional (MI region, border zone, and remote region) myocardial stress-strain relations
were computed at early- and end-diastole in the circumferential and longitudinal
directions at baseline and at three, 14, and 28 days post-MI. * p<0.05 vs. respective
baseline stress or strain value (n=8, one-way analysis of variance with post hoc LSD
comparisons).
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Figure 2.7: Diastolic myocardial stiffness
(A) Spatial maps of diastolic myocardial stiffness in the circumferential and
longitudinal directions at baseline and at three, 14, and 28 days post-MI. Inscribed
values indicate the myocardial stiffness reported as the mean value ± standard error of
the mean. (B) Region-specific change in myocardial stiffness post-MI. * p<0.05 vs.
respective baseline value, † p<0.05 vs. respective remote region value, ‡ p<0.05 vs.
respective border zone value, § p<0.05 vs. respective 14-day post-MI value (n=8, twoway analysis of variance with post hoc LSD comparisons).
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CHAPTER 3
CHANGES IN MYOCARDIAL MICROSTRUCTURE AND
MECHANICS WITH PROGRESSIVE LEFT VENTRICULAR
PRESSURE OVERLOAD

2

2

Torres W. M., Jacobs J., Doviak, H., Moore A., Freeburg L., Hoenes, A., Barlow S. C.,
Zile M. R., Shazly T., Spinale F. G. Changes in myocardial microstructure and
mechanics with progressive left ventricular overload. To be submitted to Circulation.
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3.1

ABSTRACT
Heart failure with preserved ejection fraction (HFpEF) secondary to left ventricular

pressure overload (LVPO) is a leading cause of morbidity and mortality. Treatment options
for HFpEF are limited by our poor understanding of disease phenotype and factors that
underlie its progression. Our study seeks to assess the dynamic interplay between regional
changes in myocardial geometry, microstructure, mechanical behavior, and mechanical
properties that occur in response to progressive LVPO in a large animal model. LVPO was
induced in mature pigs by progressive inflation of an implanted ascending aortic cuff for
up to five weeks. Serial echocardiography was used to quantify left ventricle (LV) chamber
stiffness and left atrial (LA) area, as well as regional myocardial strain and stiffness. Light
microscopy and second harmonic imaging (SHG) were used to evaluate myocardial
collagen content and microstructure. LVPO induced minimal perturbations in ejection
fraction and peak systolic strains, but significant elevations in LV chamber stiffness, LA
area, and regional myocardial stiffness. Analyses of myocardial collagen content and
microstructure suggested that increased myocardial stiffness is promoted by not only an
increase in collagen mass, but also a realignment of the collagen fibers and a reduction of
their undulation. Myocardial microstructural and mechanical data were integrated to
develop a novel index of local biomechanical adaptation to LVPO. Regression modeling
suggest that this index, when obtained shortly after the onset of LVPO, is predictive of
progressive increases in LV chamber stiffness. Our findings support the use of serial
biomechanical analysis b to track the progression of HFpEF and present a translational
method to stratify patient risk and assess the efficacy of pharmacological and therapeutic
approaches.
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3.2

INTRODUCTION
The rate and incidence of heart failure (HF) continues to escalate and recent

statistics have identified this disease as the leading cause of morbidity and mortality –
eclipsing all other chronic diseases.30 While significant progress has been achieved in
therapeutic retardation or elimination of other major illnesses such as cancer, these
advancements have not been as forthcoming for HF. One contributory factor for this is that,
unlike cancer which is classified by morphology, cell type, and molecular/genetic profiles,
HF has been historically considered as a single entity fundamentally defined by
symptomatology. However, it is also recognized that HF arises from distinctly different
etiologies, which, in turn, have demonstrated distinctly different therapeutic responses and
clinical outcomes.31,32
While the precise categorization of HF is continuously evolving, a generalized
dichotomy can be made between patients presenting with or without significant left
ventricular (LV) pump dysfunction. Specifically, if LV ejection fraction (EF) is below
45%, this is defined as HF with reduced EF (HFrEF), whereas if HF symptoms are present
and EF is above this value, then it is defined as HF with a preserved EF (HFpEF). Using
this HF classification scheme, it has been estimated that patients with these HF phenotypes
are equally distributed.31 Randomized clinical trials using combinatorial pharmacology or
device-driven therapies have demonstrated significant improvement in HF progression and
clinical outcomes in patients with HFrEF, but not in patients with HFpEF.92–99 In addition,
while the functional progression of HFrEF can be monitored by serial assessment of
changes in EF, the natural history of HFpEF is not as easily tracked or well understood.51,100

49

As a result, advancements in the prognosis and strategic interventions for HFpEF have
been met with challenges.
One rate limiting step in the research progress for HFpEF is a paucity of
translationally relevant animal models that recapitulate key features of this HF
phenotype.101,102 Specifically, HFpEF can arise from progressive and prolonged LV
pressure overload (LVPO) rather than from an acute pathological stimulus such as
myocardial ischemia, which progresses to HFrEF.103–106 In addition, a key component in
the progression of HFpEF is the development of LV diastolic dysfunction, which requires
sensitive measures of LV diastole and can be difficult to assess in a serial manner.107,108
We have previously established a porcine model of progressive LVPO, which resulted in
significant LV hypertrophy with stable EF, but with evidence for impaired diastolic
function, consistent with the clinical phenotype of HFpEF.109
The overall goal of this study was to utilize this relevant pre-clinical model to parse
out the relationship between the LV geometry, collagen microstructure, mechanical
behavior, and mechanical properties in development of HFpEF. The central hypothesis of
this study was that LV remodeling in response to LVPO is characterized by an increase in
collagen mass and a change in the collagen microstructure. We posit that these changes
will be the driving factor behind progressive changes in both LV chamber stiffness and
myocardial mechanical properties. To that end, in the present study we employ a
combinatorial approach of non-invasive imaging techniques along with an advanced
optical analysis of the collagen microstructure to improve upon the current understanding
of the mechanisms which give rise to the progression of HFpEF.
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3.3

METHODS
The present study induced progressive LVPO in pigs for up to a 5 week period,

over which regional myocardial strain and stiffness were quantified using speckle tracking
echocardiography and, at the terminal time point, myocardial collagen content and
microstructure using quantitative histomorphometry and second harmonic generation
imaging.7,57,61,110–113 These functional and serial results were then examined with a focus
upon identifying factors that would contribute to and potentially predict changes in LV
chamber stiffness, a hallmark of HFpEF progression.47,50,109,114–119
3.3.1 Aortic Cuff Placement
Yorkshire pigs (n=15, 15.8±0.6 kg, Hambone Farms, Orangeburg, SC) were
anesthetized with isoflurane (3%/1.5L/min) and nitrous oxide (0.5L/min). Through a left
thoracotomy, the pericardium was incised and a 12 mm inflatable silastic vascular cuff
(Access Technologies, Skokie, IL) was secured around the supracoronary ascending aorta
without inducing aortic constriction. A uniform length of silastic tubing was connected to
a subcutaneous access port (Access Technologies, Skokie, IL) for subsequent serial
hydraulic mediated expansion of the aortic cuff. The animals were allowed to recover for
one week. Twelve age-matched referent control pigs were also used for comparative
analyses. A prospective power analysis assuming a doubling of key response variables
relative to the subject-matched baseline value and a standard error of measurement of 40%
yielded a minimum study power of 0.80 for all experimental groups. All animals were
treated and cared for in accordance with the National Institutes of Health Guide for the
Care and Use of Laboratory Animals (Eighth Edition. Washington, DC: 2011) and all
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experimental protocols were approved by Institutional Animal Care and Use Committees
at the University of South Carolina.
3.3.2 Progressive Induction of LVPO
Following the one-week recovery period, the cuff was inflated through the access
port (via 0.45 mL glycerol) to achieve a specific target gradient of 75 mmHg across the
cuff and induce LVPO. At weekly intervals thereafter, the cuff was further inflated
(0.25 mL increments) to cause a stepwise increase in the pressure gradient (25 mmHg
increase/inflation). At either four (n=7) or five weeks (n=7) post-PO, the animals were
again anesthetized (5% isoflurane) and the LV was harvested.
3.3.3 Standard Echocardiography
Standard echocardiography was performed weekly throughout the study (GE Vivid
E9 with XDclear Ultrasound System: M5S (1.5-4.6 MHz) transducer probe). Left
ventricular and left atrial dimensions and function were assessed by two-dimensional and
M-mode echocardiographic studies. The transthoracic images were acquired from a right
parasternal approach as well as an abdominal/sub xyphoid approach. The LV was imaged
in the short- and long-axes. The short-axis views were taken at the level of the papillary
muscles. End-diastolic volume (EDV), end-systolic volume (ESV), and EF were calculated
using the biplane method of disks. Left atrial (LA) area was determined from the
anteroposterior dimensions acquired from the parasternal long-axis view. Additionally,
wall thickness and LV internal dimension were collected at early- and end-diastole for each
of the six conventional echocardiogram segments of the LV in the parasternal long-axis
and papillary level short-axis. Finally, following the convention established by Devereux
and colleagues, LV mass was estimated from M-mode measurements.4 Echocardiographic
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studies under identical sedation/acquisition conditions were performed at weekly intervals
until the terminal timepoint.
3.3.4 Definition of Normal Range for Left Ventricular mass
LV mass measurements (computed as described above) were collected from a
cohort of 100 male Yorkshire pigs (body weights ranging from 13.4 kg to 33.1 kg) that
were part of this laboratory’s prior studies completed between 2012-2017. A normogram
for LV mass as a function of body weight was generated by fitting a linear regression
through the resultant data set with a 95% confidence interval. This normogram provides a
basis to assess pressure-induced elevations in LV mass with due account of normal growth.
3.3.5 Terminal Evaluation of Global and Regional Left Ventricular Function
In a subset of referent control (n=5) and banded (n=5) pigs, LV pressure and
dimensions were obtained. Briefly, the pigs were anesthetized with fentanyl (50 µg) and
propofol (100 mg), and a cardiac catheter introducer with a side-arm (9F, Medtronic,
Minneapolis, MN) connected to a pressure transducer was placed in the right carotid artery
and advanced to the ascending aorta. After which, a multi-lumened thermodilution catheter
(7.5F, Baxter Healthcare Corp., Irvine, CA) was advanced through the right external
jugular vein and positioned in the pulmonary artery. Pulmonary capillary wedge pressure,
a surrogate for end-diastolic pressure (PED), was measured using conventional methods.120
Afterwards, a microtipped transducer (7.5F, Millar Instruments Inc., Houston, TX) was
placed in the LV through a small apical stab wound. Pressure data was recorded at a
sampling frequency of 100 Hz and digitized (Ponemah, Harvard Bioscience Inc., Holliston,
MA). Following the placement of the instrumentation, an ultrasound transducer (GE Vivid
E9 with XDclear Ultrasound System: M5S (1.5-4.6 MHz) transducer probe) was positioned
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for transthoracic imaging of the LV short-axis and measurement of continuous LV volume
and wall thickness.121 Steady-state LV function was determined with simultaneous
acquisition of pressure and echocardiographic data with the ventilator temporarily
suspended in order to prevent respiratory artifact. Following steady-state measurements,
LV preload was altered with sequential occlusion and release of the inferior vena cava with
vascular ligature. Again, simultaneous pressure and echocardiographic data were collected
during occlusion and release.
After data acquisition was complete, the digitized pressure and LV dimension data
were aligned using the R-wave of the simultaneously recorded ECG from each modality.
The aligned pressure and dimension data for the steady-state and caval occlusion cardiac
cycles were used to determine the regional myocardial stiffness constant and LV chamber
stiffness, respectively, using the methods derived by Mirsky and Pasipoularides.21,22
3.3.6 Non-Invasive Estimation of End-Diastolic Pressure and Chamber Stiffness
While direct measurements of LV pressure and chamber stiffness via cardiac
catheterization have been accepted as the gold standard, non-invasive estimates of these
response variables were necessary in order to track the progression of disease and LV
remodeling. Accordingly, obtained measurements of pulmonary capillary wedge pressure
and temporally-matched LA area measurements in a subset of referent control (n=5) and
banded (n=8) animals were used to identify an expression for non-invasive estimation of
end-diastolic pressure, specifically 𝑃𝐸𝐷 = 1.88𝑒 0.16(𝐿𝐴 𝑎𝑟𝑒𝑎) (R2=0.91). After applying this
regression-based non-invasive estimation of 𝑃𝐸𝐷 to the entire study cohort, a non-invasive
surrogate of LV chamber stiffness (𝐾𝐶∗ ) was computed as the ratio between 𝑃𝐸𝐷 and
EDV.122
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3.3.7 Speckle Tracking Echocardiography
Three consecutive digital loops of the two-dimensional echocardiography for the
long-axis and short-axis were stored on a hard disk and transferred to a workstation
(EchoPac, Vingmed, General Electric) for post-processing. For each echocardiographic
digital loop, a region of interest (ROI) was defined at the onset of the R-wave by manually
tracing the endocardial and epicardial borders. The ROI was then discretized with a spatial
mesh of acoustic clusters to be tracked on a frame-to-frame basis throughout the cardiac
cycle (R-R interval).7 The end of systole was defined as the point at which the LV crosssectional area was at a minimum. After the semi-automated grouping of acoustic clusters
in accordance with six predetermined anatomical locations, regional tracking quality was
assessed, and the ROI was manually adjusted by the operator to improve tracking quality
where necessary. Successful tracking of the ROI allows for the definition of segmental
lengths, which are computed at end diastole (L0) and continuously throughout the cardiac
cycle (L). Local segmental strains (ε) and strain rates (γ) are then computed as:
𝜀=

𝐿−𝐿0

𝛾=

𝐿0

=

∆𝐿
𝐿0

(∆𝐿/∆𝑡)
𝐿0

(3.1)
(3.2)

where Δt is the relative time in the cardiac cycle. Peak strain and diastolic strain rate were
quantified in the two normal directions, circumferential (short-axis) and longitudinal (longaxis), at the endocardial, mid-wall, and epicardial surfaces. Global strain values were
calculated from the total length of all six segments. Obtained segmental strain and strain
rate data were assessed for intra-observer variance by calculating the intra-class correlation
coefficient for a single operator under the assumption that systematic differences are
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relevant. The intra-class correlation coefficient for all measures of strain and strain rate
ranged from 0.94 to 0.99.
3.3.8 Mean Wall Stresses
We modified a thick-walled ellipsoidal model proposed by Janz to compute mean
wall stresses.24 The mean circumferential wall stress (𝜎𝐶 ) was computed as:
𝜎𝐶 =

𝑃𝑟 2
𝑡
2

2𝑡(𝑟+ )

(3.3)

where (r) is the inner radius, (t) is the wall thickness, and (P) is the LV pressure. For the
purposes of this study, (P) was assumed to equal zero at the onset on diastole and the PCWP
at end-diastole.
The mean longitudinal wall stress (𝜎𝐿 ) was computed as:
𝜎𝐿 =

𝑃𝑟 2
2𝑡(𝑠𝑖𝑛𝜃)(𝑟+

(3.4)

𝑡(𝑠𝑖𝑛𝜃)
)
2

where (Φ) is the angle between the normal vector from the endocardium at the ROI and
the axis of revolution in the truncated ellipsoid model.
3.3.9

Regional Diastolic Myocardial Stiffness
Obtained values for mean wall stresses and segmental strains at the onset of diastole

and end-diastole enabled calculation of regional diastolic myocardial stiffness in both the
circumferential and longitudinal directions. The slope of the line between these two points
in the stress-strain plane, developed in either the circumferential or longitudinal direction
and referenced to the defined anatomical locations, was used to compute the regional
diastolic myocardial stiffness (KMR) as:
𝜎

𝜅𝑀𝑅 = |𝜀𝐸𝐷|
𝐷0
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(3.5)

where 𝜎𝐸𝐷 and 𝜀𝐷0 are the end diastolic mean wall stress and segmental strain at the onset
of diastole, respectively.
3.3.10 Second-Harmonic Generation Imaging
Upon terminal heart harvest, a 1-inch thick bisection of the left ventricle was fixed
in 10% formalin – preserving the native orientation and configuration of the collagen fibers
– and refrigerated for histological evaluation. The LV lateral free-wall myocardium was
later sectioned into thin, 200 µm sections using a vibratome and placed on the motorized
stage of a multiphoton microscope (Leica TCS SP8 MP, Leica Microsystems). Shortpulsed infrared lasers were used to create non-linear polarization effects in the form of
second-harmonic generation (SHG) signals at a magnification of 25x. Images were
acquired for a fixed sample area of 0.2 mm2 at depth intervals of 1.5 µm.
3.3.11 Automated Tracing of Individual Collagen Fibers
Two-dimensional images acquired from the multiphoton microscope were
converted to 8-bit greyscale and virtually stacked in three-dimensions using the Amira
software package.123 For the fully-automated tracing of individual collagen fibers, we
modified the previously described techniques developed for electron tomography,124,125
which have been packaged into the XTracing filament detection extension available for
Amira. In brief, this tracing algorithm consists of two main steps: template matching and a
line search approach. A correlation field is generated by computing the cross-correlation
of the voxels in the three-dimensional stack with a cylindrical template. This cylindrical
template mimics a short collagen fiber segment with a mask radius of 5 µm and a length of
20 µm. The correlation was computed for each voxel on a NVIDIA Quadro M2000
graphics processing unit. The line search approach was then used to iteratively identify the
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voxels on the centerline of each collagen fiber. From an initial seed point, a search cone
spanning 20 µm and 45 degrees was used to identify candidate points that were scored on
the basis of continuity, curvature, and deviations from the orientation field. The line search
stops when the search cone fails to identify candidate points with scores above the
minimum threshold.
3.3.12 Characterization of the Collagen Structure
Each collagen fiber was evaluated with respect to orientation and undulation. Two
angles were used to define the fiber orientation. The azimuthal angle (φ) refers to angle
from the positive radial axis of the fiber’s projection on the longitudinal-radial plane, where
φ=0º is then the radial direction. The elevation angle (ϑ) refers to the angle from the positive
circumferential axis of the fiber’s projection on the circumferential-longitudinal plane,
where ϑ=0º and ϑ=90º correspond with the circumferential and longitudinal directions,
respectively. Fiber undulation (𝑢) is defined as the ratio between the path length (𝑙𝑝 ) and
the end-to-end length (𝑙𝑒 ) of a given fiber.
𝑢=

𝑙𝑝
𝑙𝑒

(3.6)

3.3.13 Collagen Content by Light Microscopy
LV septal and lateral sections were stained with picrosirius red (PSR) and viewed
with polarized light at a magnification of 40x. Five fields were chosen at random from the
mid-myocardium. Fields with large blood vessels were excluded from the analysis.
Collagen volume fraction (CVF) was calculated as the area stained by PSR divided by the
total area of interest using ImageJ software.126
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3.3.14 Statistical Analysis
Data are reported as the mean ± standard error of the mean. Comparative analyses
were performed using a one-way analysis of variance followed by pair-wise comparisons
using the least significant difference post hoc study. For the assessment of the relative
change from baseline, a t-test was performed whereby significance of the transformed data
were determined using a null hypothesis of a zero-mean value. For SHG collagen fiber
characterization, at each timepoint, all values of φ, ϑ, and 𝑢 were pooled and binned into
100 equally sized bins. The resulting frequency distributions were subjected to a KruskalWallis one-way analysis of variance for non-parametric comparisons across different
timepoints. A multiple linear regression model with inputs derived at one-week post-PO
was used to predict the relative change in 𝐾𝐶∗ at two-weeks, three-weeks, four-weeks, and
five-weeks post-PO, and the p-value and t-statistic were calculated for each of the input
variables. A Spearman’s rank correlation analysis was used to interrelate experimental
response variables at four- and five-weeks post-PO. All statistical analyses were performed
with SPSS software (version 24.0, SPSS Inc) or MATLAB (version R2018a, The
MathWorks Inc). A p-value of less than 0.05 was considered statistically significant.

3.4

RESULTS

3.4.1 Left Ventricular Geometry and Systolic Function
The progressive hydraulic inflation of the aortic cuff resulted in significant
hypertrophy of the LV as compared to an age-matched referent control LV as a result of
the narrowing of the aortic lumen (Figure 3.1A). This hypertrophic response, growth that
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superseded that which can be expected due to normal growth, occurred in a time-dependent
fashion over five weeks (Figure 3.1B). In contrast, the ratio of LV EDV to body weight
was preserved and systolic function, assessed by LV ejection fraction, was modestly
increased relative to baseline at both four- and five-weeks post-PO. Significant increases
in the LV mass/volume ratio and LA area were observed. The effects of PO on LV function
and geometry are summarized in Figure 3.2.
3.4.2 Left Ventricular Diastolic Function
Following established convention, chamber stiffness was determined from
pressure-volume relations at the four- or five-week post-PO terminal timepoint and agematched referent control pigs (Figure 3.3A). Significant increases in chamber stiffness
were observed in the banded animals (Figure 3.3B). Similarly, increases in the previouslydefined non-invasive surrogate for chamber stiffness (𝐾𝐶∗ ) were observed in the banded
animals relative to baseline observations by one-week post-PO and progressive increases
through five-weeks post-PO. Post-processing via Pearson correlation analysis yielded
significant correlation between these two measurements of chamber stiffness (ρ=0.75,
p<0.05). As such, for the duration of the results and discussion, we will use 𝐾𝐶∗ as the
predominant measure of LV chamber stiffness because it can be measured in a serial
manner.
3.4.3 Left Ventricular Collagen Content and Organization
Photomicrographs of picrosirius red-stained slides enabled quantification of
myocardial collagen content (Figure 3.4). CVF was indistinguishable at four- versus fiveweeks post-PO, but both were more than doubled compared to the referent control value.
The increase in collagen content was coupled with significant changes in collagen fiber
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microstructure (Figure 3.5). In all three layers of the LV, observed fiber undulation
distributions indicated a significantly higher coincidence of less wavy fibers at five-weeks
post-PO compared to referent control (Figure 3.5B). In terms of ECM organization,
collagen fiber angle distributions on the circumferential-longitudinal plane in the
epicardium and endocardium were significantly shifted towards the circumferential axis by
five weeks and four weeks post-PO, respectively (Figure 3.5C). Collagen fiber angle
distributions on the radial-longitudinal plane were mostly preserved during the five weeks
of this study (Figure 3.5D).
3.4.4 Assessment of Biomechanical Behavior and Properties
STE was used to serially track LVPO-induced changes in regional peak strain,
diastolic strain rate, and diastolic myocardial stiffness (Figure 3.6). Peak strain, taken as
an index of regional systolic function, is generally preserved in the longitudinal direction
and moderately elevated in the circumferential direction by one-week post-PO. Regional
diastolic function, assessed via diastolic strain rate, was found to be impaired in the
longitudinal direction with a reduction relative to baseline values observed in the
endocardium and mid-myocardium by three-weeks or four-weeks post-PO, respectively.
In contrast, circumferential diastolic strain rate was mostly preserved. LVPO was found to
have a significant effect on diastolic myocardial stiffness in both the circumferential and
longitudinal directions. Regional measurements of diastolic myocardial stiffness were
validated against the measurements obtained from the invasive catheterization
measurements defined above and a significant correlation between the two was observed
(ρ=0.70, p<0.05). The global diastolic myocardial stiffness, taken as the average stiffness
computed among all defined regions, significantly increased by four-weeks post-PO in the
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circumferential direction and by two-weeks post-PO in the longitudinal direction, with
progressive increases subsequently occurring in both directions.
3.4.5 Correlation Between Regional Composition and Biomechanical Behavior and
Properties
A correlation matrix was developed to relate the relative change in biomechanical
response metrics and geometrical, compositional, and microstructural features of the
myocardium at the terminal study timepoints (Figure 3.7). Surprisingly, subject-specific
changes in wall thickness and collagen content did not significantly correlate with the
changes in biomechanical response metrics, while ECM microstructure did so in an
intuitive manner. Specifically, a reduction in fiber undulation (𝑢→1) was correlated with
increased myocardial stiffness in all three layers of the LV. Furthermore, an inverse
correlation was observed between the elevation angle and myocardial stiffness – linking a
preferential fiber orientation towards the circumferential axis (ϑ→0°) to higher
circumferential myocardial stiffness.
3.4.6 Predicting Changes in LV Chamber Stiffness
To develop an index of biomechanical adaptation of the myocardium to LVPO, we
examined the subject-specific relationship between regional changes in diastolic
myocardial stiffness and wall thickness. Specifically, we computed the slope of a linear
regression in the circumferential stiffness-thickness plane (𝜕𝐾𝑀𝑅 /𝜕𝐻) developed with
measurements from the six defined myocardial regions at one-week post-PO (Figure
3.8A). The observed inverse relationship, when computed for an individual subject, is
posited as an index of adaptation in the sense that the more negative the slope, the more
the myocardium has mechanically-compensated for increased wall thickness such that the
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concomitant increase in 𝐾𝐶∗ is less severe. This index of adaptivity was combined with the
∗
measurement of the current chamber stiffness (𝐾𝐶,1−𝑤𝑒𝑒𝑘
) in a multiple linear regression

model of the form:
∗
𝐾𝐶,𝑝𝑟𝑒𝑑.
=𝑎

𝜕𝐾𝑀𝑅
𝜕𝐻

∗
+ 𝑏(𝐾𝐶,1−𝑤𝑒𝑒𝑘
) + 𝑐(𝑇) + 𝑑,

(3.7)

where 𝑎, 𝑏, 𝑐, and 𝑑 were fitting parameters and 𝑇 was the time (in days) of the
echocardiographic analysis after the initial placement of the aortic cuff. A post-hoc Pearson
correlation analysis of the predicted change in chamber stiffness versus the experimentally
measured result demonstrates a strong correlation between the two numbers (Figure 3.8B)
(ρ=0.75, R2=0.57, p<0.05). After the determination of the t-statistic for each of the four
fitting coefficients, all were deemed to be statistically significant with a significance level
of 5% (0.05).

3.5

DISCUSSION

3.5.1 Study Overview
The clinical syndrome of HFpEF burdens over three million patients in the United
States alone and carries a five-year mortality rate of approximately 50%.30,31,127 While there
are viable pharmacological and therapeutic options available for those suffering from
HFrEF, HFpEF treatments are limited by our poor understanding of disease phenotype,
etiology, and progression.51,92–100 The present study seeks to address this knowledge gap
with a series of regional measurements of myocardial mechanics and microstructure in a
porcine model of LVPO with retained systolic function. Using a combination of noninvasive serial measurements and ex-vivo analysis, the significant and noteworthy findings

63

from this study were three-fold. First, our results show that in addition to the expected
increase in LV 𝐾𝐶∗ , progressive changes in regional diastolic myocardial stiffness occur
over five-weeks post-PO and provide a promising basis for improved clinical phenotyping
of HFpEF. Second, elevated myocardial stiffness following LVPO is modulated by not
only increased collagen content, but also changes in collagen fiber alignment and
undulation. Third, through pig-specific analysis of regional changes in myocardial stiffness
and wall thickness shortly following the onset of LVPO, we have identified a novel method
to predict the extent of adverse LV chamber stiffening observed at later times post-PO.
Thus, using a pre-clinical model we have shown the viability of serial biomechanical
analysis as a basis to track the progression of HFpEF and present a translational method to
stratify patient risk and assess the efficacy of pharmacological and therapeutic approaches.
3.5.2 Serial Tracking of Myocardial Biomechanics and Mechanical Properties
While the progression of HFpEF can be difficult to assess and track in a clinical
setting, this animal model resulted in LV hypertrophy and hallmark characteristics of
HFpEF in accord with previous studies.109 From a biomechanical perspective, hypertrophy
is the primary adaptive response of the myocardium to LVPO that mitigates the
concomitant increase in wall stress.128,129 Partially as a result of hypertrophy, progressive
and significant elevations in diastolic 𝐾𝐶∗ also occur over the time course of this study –
again falling in line with a multitude of prior studies.47,109,114,115,130,131 However, a
comparison of late study time points (four- versus five-weeks post-PO) suggests that
structural stiffness elevations are not simply governed by the addition of myocardial mass,
but also the local mechanical stiffening of the myocardium itself. While the co-dependence
of aberrant LV structural mechanics on both myocardial geometry and mechanical
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properties is expected in all modes of HF, our results provide novel directional and regional
detail on PO-induced elevations in diastolic myocardial stiffness (KMR) and, importantly,
inform temporal relation to elevations in 𝐾𝐶∗ .18,109,130,132,133 Despite the substantial changes
in geometry, KMR, and 𝐾𝐶∗ , baseline peak strain and diastolic strain rate were largely
retained. While there are a number of recent clinical studies which suggest that HFpEF is
marked by a reduction of global longitudinal strain, this study (along with others) shows
modest, if any, early changes in regional or global strain and diastolic strain rate. This
finding suggests that global longitudinal strain values may be used to sub-classify HFpEF
in the early stages of disease progession.111,134–137
3.5.3 Microstructural changes with LVPO
A consensus has emerged that the extracellular matrix (ECM) is extensively altered
in the case of HFpEF secondary to LVPO.138 These changes, primarily excessive ECM
deposition by fibroblasts and changes in the relative balance between matrix
metalloproteinases (MMPs) and the tissue inhibitors of the MMPs, are not readily
reversible and contribute to impaired diastolic function.138–142 This excessive ECM
deposition, most notably increased collagen content, has been associated with the
progressive stiffening of the LV and myocardium.143–146 While we too observe LVPOinduced increases in CVF, correlation analyses suggest that changes in collagen fiber
microstructure further modulate myocardial stiffness at later post-PO time points. As first
established in the context of vascular mechanics, the inherent undulation of tissueembedded collagen fibers implies a gradual contribution to load-bearing under increasing
tension.147 Likewise in the myocardium, a collagen fiber with relatively less undulation
will be recruited to load-bearing at relatively lower loads (pressure), and thus lead to
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increased KMR. Our regional analysis indeed showed correlation between the reductions in
fiber undulation and increases in KMR. We posit that in the cycle of degradation and
synthesis of collagen that occurs secondary to LVPO, the newly deposited collagen is
embedded in the ECM under a higher degree of tension due to the elevated intraventricular
pressure, which in turn reduces mean undulation and increases passive stiffness. We also
show significant collagen fiber realignment concordant with disease progression. Much
like previously reported findings of the infarcted myocardium, we observe that LVPOinduced hypertrophy is associated with an increased circumferential alignment of collagen
fibers.34 Taken together, these findings suggest that changes in fiber microstructure and
alignment contribute to the recorded elevations in both circumferential and longitudinal
KMR.
3.5.4 Early Stratification of Subject-Specific Risk
It is accepted that soft tissue growth and remodeling are adaptive responses to cope
with sustained changes in the local mechanical environment (i.e. stresses and strains) of
mechanosensitive cells.148–151 In 1995, Fung proposed a kinematic mass-stress relationship
with the fundamental idea that every biological tissue has mechanisms by which to
maintain a certain homeostatic stress state.152 Thus, elevations in stress (possibly due to
increased loading) would result in a compensatory increase in mass, while reductions in
stress would result in the opposite – effectively restoring the tissue to its native homeostatic
stress state. While modulation of growth facilitates the maintenance of the local
homeostatic stress state, we posit that in an optimally adaptive tissue, local changes in mass
must also be coupled with proportionally opposing changes in local stiffness so as to
maintain structural compliance. As it applies to the present study, at one-week post-PO, we
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observed that local wall thickening coincides with relatively less local stiffening (or even
reductions in local stiffness) throughout the myocardium. Based on this notion of optimal
adaptation, we take the degree to which an inverse thickening-stiffening relation is manifest
to reflect the overall LV adaptive capacity of the individual subject. We defined a related
index of biomechanical adaptation and showed that it, along with 𝐾𝐶∗ also obtained at this
early time point, can be used to predict subsequent elevations in 𝐾𝐶∗ (Figure 3.7). Though
it does little to address the underlying mechanisms, the proposed model may prove to be a
clinically-relevant means to predict an individual patient’s progression to HFpEF and
therefore may influence clinical decision making in regard to disease prevention or
management.50,116–119 Furthermore, these findings give rise to a potential target for future
studies as we seek to understand the epidemiological mechanisms which drive the varying
degrees of biomechanical adaptive capacity on a subject-to-subject basis.
3.5.5 Study Limitations and Summary
For the first time, a serial characterization of myocardial mechanics and the
organization/configuration of collagen within the ECM has been performed in a large
animal model of LVPO. Furthermore, we present a novel mechanics-based method to
predict the subject-specific severity of LV chamber stiffening, a central component of the
HFpEF phenotype. However, several study limitations should be considered upon
evaluation of our conclusions. Firstly, although the porcine model employed in our study
enabled unique measurements with potential to advance the phenotyping of HFpEF, this
animal model does not emulate any of the co-morbidities typically observed in patients
with HFpEF (i.e. metabolic or renal dysfunction). Additionally, while the indices of
diastolic dysfunction (i.e. LA area, LV chamber stiffness) suggest that these animals are
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on a trajectory to HFpEF, the study was completed prior to a robust symptomatic
development of HFpEF. Finally, while this study provides a promising method to predict
HFpEF progression based on early observations of LV biomechanics, we did not explore
the extent to which our results/predictions would vary in the context of a therapeutic
intervention. Future studies in a clinical setting would be needed to further validate our
findings and importantly evaluate the translational potential of using early changes in LV
biomechanics following the onset of LVPO to predict those patients at greatest risk for the
development and progression of HFpEF.
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Figure 3.1: Pressure overload-induced hypertrophy of the LV
(A) Representative transthoracic echocardiographic views of the LV short-axis at the
level of the papillary muscle along with preserved bisections of the intact ventricles and
ascending aorta for both study groups. A clear and obvious thickening of the LV
occurred as a result of LVPO. The aortic cuff significantly reduced the cross-sectional
area of the aortic lumen. (B) LV mass obtained at baseline and over five-weeks postPO superimposed on a normogram of LV mass relative to body weight. The observed
increase in LV mass indicates a pressure-induced hypertrophic response. (BL – threeweeks post-PO: n=15; four-weeks post-PO: n=14; five-weeks post-PO: n=7)
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Figure 3.2: Echocardiographic indices of the progression to HFpEF.
(A) Baseline values of LV end-diastolic volume/body weight ratio, (B) LV ejection
fraction, (C) LV mass/volume ratio were largely maintained over the study period, and
(D) LA Area progressively increased over five-weeks post-PO. * p<0.05 vs. baseline
value, + p<0.05 vs. one-week value, # p<0.05 vs. two-weeks value, ‡ p<0.05 vs. threeweeks value. (BL – three-weeks post-PO: n=15; four-weeks post-PO: n=14; five-weeks
post-PO: n=7)
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Figure 3.3: Evaluation of left ventricular chamber stiffness.
(A) Gold-standard techniques were used to derive measurements of left ventricular
chamber stiffness in a subset of referent control (n=5) and pigs four- or five-weeks postPO (n=5) from pressure-volume relationships. A significant reduction in LV chamber
compliance was observed in the animals four- to five-weeks post-PO – as evidenced by
the included representative examples. (B) A non-invasive surrogate of LV chamber
stiffness (𝐾𝐶∗ ) was generated and validated against the gold-standard measurements of
chamber stiffness. While differing in magnitude, a correlative response was observed
between the two measurements. (C) This non-invasive measurement of chamber
stiffness allows for the serial assessment of diastolic function and demonstrates
progressive stiffening of the LV chamber through the five weeks of the study. * p<0.05
vs. baseline value, + p<0.05 vs. one-week value, # p<0.05 vs. two-weeks value, ‡ p<0.05
vs. three-weeks value, § p<0.05 vs. four-weeks value. (BL – three-weeks post-PO: n=15;
four-weeks post-PO: n=14; five-weeks post-PO: n=7)
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Figure 3.4: Quantification of collagen content.
(A) Transmural sections of the LV mid-myocardium were stained with picrosirius red
and imaged at 40x magnification. (B) Collagen volume fraction (CVF) was computed
for samples corresponding to referent control (n=7), four-weeks post-PO (n=6), and
five-weeks post-PO (n=7). * p<0.05 vs. referent control value.
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Figure 3.5: Characterization of collagen fiber structure and orientations.
(A) Three-dimensional stacks of two-dimensional images acquired from second
harmonic generation enabled reconstruction of collagen fibers and subsequent
representation as vectors in a Cartesian coordinate system for samples corresponding to
referent control (n=5), four-weeks post-PO (n=6), and five-weeks post-PO (n=7). (B)
Regional fiber undulation (𝑢) distributions were computed for the epicardium (EPI),
mid-myocardium (MYO), and endocardium (ENDO) based on reconstructed fiber
geometries. Two fiber-specific angles were computed to quantify fiber orientation. (C)
The elevation angle, ϑ, was computed from the circumferential-longitudinal plane. An
angle of ϑ=0° indicates fiber alignment with the circumferential axis. (D) The azimuthal
angle, φ, was computed from the longitudinal-radial plane. An angle of φ=0º indicates
fiber alignment with the radial axis. * p<0.05 vs. referent control value, § p<0.05 vs.
four-weeks value.
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Figure 3.6: Biomechanical response and properties.
Peak strain (left column) and diastolic strain rate (middle column) underwent similar
changes in the epicardium, mid-myocardium, and endocardium over five weeks postPO. The mean regional diastolic myocardial stiffness (|𝜅𝑀𝑅 | right column) was found
to progressively increase over five-weeks post-PO in both the circumferential and
longitudinal directions. * p<0.05 vs. baseline value, + p<0.05 vs. one-week value,
‡
p<0.05 vs. three-weeks value. (BL – three-weeks post-PO: n=15; four-weeks post-PO:
n=14; five-weeks post-PO: n=7)
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Figure 3.7: Biomechanical, geometrical, compositional, and microstructural
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Figure 3.8: A method for predicting the late PO-induced increase in LV chamber
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and LV chamber stiffness.
(A) Region-matched changes in wall thickness and circumferential diastolic myocardial
stiffness obtained at one-week post-PO (𝐾𝑀𝑅 ), reported as the mean values among all
animals (n=14) in the circumferential direction. The observed inverse correlation is
indicative of adaptive remodeling that mitigates increased wall stress with PO, whereby
we propose the degree of subject-specific adaptivity is related to the degree to which
local wall thickening is compensated for by a relatively muted increase in local diastolic
myocardial stiffness. (B) A predicted value for changes in LV chamber stiffness relative
∗
to baseline (𝐾𝐶,𝑝𝑟𝑒𝑑.
) at three-weeks, four-weeks, and five-weeks post-PO was
generated through multiple linear regression modeling of subject-specific response
variables using LV chamber stiffness (𝐾𝐶∗ ) and (𝜕𝐾𝑀𝑅 /𝜕𝐻) taken at one-week post-PO
∗
as input variables. 𝐾𝐶,𝑝𝑟𝑒𝑑.
significantly correlated with the experimentally measured
values, suggesting that measurements obtained at one-week post-PO can predict the
severity of subsequent LV chamber stiffening.
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CHAPTER 4

ECHOCARDIOGRAPHIC QUANTIFICATION OF THE PASSIVE
MECHANICAL PROPERTIES OF THE LEFT VENTRICULAR
MYOCARDIUM

3

3

Torres W. M., Spinale F. G., Shazly T. Echocardiographic quantification of the passive
mechanical properties of the left ventricular myocardium. Submitted to Journal of the
American Society of Echocardiography on March 1st, 2019.
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4.1

ABSTRACT
Advancing assessment of the rate and extent of left ventricular (LV) remodeling

holds great value for heart failure (HF) diagnosis and prognosis. While global longitudinal
myocardial strain determined by speckle-tracking echocardiography (STE) has been
considered as a remodeling response variable, reported strain measures are limited by the
masking of regional differences and a dependency on hemodynamic load. Our study entails
a novel extension of two-dimensional STE to quantify the regional passive mechanical
properties of the LV myocardium – providing a clinically accessible, load-independent
response variable that reflects the LV remodeling process. An inverse finite element
analysis was employed with a pattern search optimization algorithm to identify regional
indices of passive myocardial stiffness based on STE-derived regional longitudinal strains
and wall geometries. Our framework was applied in two distinct porcine models of early
LV remodeling, specifically following myocardial infarction and onset of LV pressure
overload. Obtained results elucidate regional and temporal changes in passive myocardial
stiffness throughout early LV remodeling in both animal models. Changes in passive
myocardial stiffness demonstrate enhanced sensitivity as compared to changes in global
strain, and strongly correlate with conventional indices of LV remodeling. Regional
passive myocardial stiffness can be noninvasively determined via STE data processing
using an inverse finite element framework and provides a sensitive index of LV remodeling
with potential to aid in HF diagnosis and prognosis.
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4.2

INTRODUCTION
Heart failure (HF) is a clinical syndrome which most commonly arises from two

potentially overlapping physiological causes: impaired left ventricular (LV) ejection
performance or impaired LV filling. In terms of HF phenotyping, impaired LV ejection
performance is defined as HF with reduced ejection fraction (HFrEF) while impaired LV
filling with a stable ejection performance is defined as HF with preserved ejection fraction
(HFpEF). These HF phenotypes emerge from distinctly different etiologies, whereby
HFrEF commonly occurs secondary to myocardial injury/ischemia and HFpEF arises from
a chronic LV pressure overload such as hypertension. In both HFrEF and HFpEF, the LV
undergoes progressive changes in geometry, composition, and mechanical properties
collectively known as LV remodeling.52,56,153–156 While nominally an adaptive response,
LV remodeling underlies HF progression, and consequently its serial assessment holds
great value in HF diagnosis and prognosis.157–160
Although commonly used in a clinical setting, global measures of LV function such
as ejection fraction or volumes can be insensitive to early changes in LV performance and
thus fail to identify HF development and progression. Alternatively, the assessment of
regional function through the quantification of LV myocardial strain, defined as the
fractional change in length of a myocardial segment relative to its baseline length, has
gained traction recently as a comparatively sensitive index of LV remodeling.161
Developments in ultrasound-based imaging technology enable serial quantification of LV
myocardial strain in a clinical setting. Specifically, speckle-tracking echocardiography
(STE) tracks segmental length changes via the relative movement of intrinsic acoustic
markers of the LV to quantify regional myocardial strain.7 The analysis of both global
79

(fractional change in total segmental length) and regional longitudinal strain using STE can
provide diagnostic information in disease states ranging from myocardial infarction to
cardiotoxicity.64,65,122,134,137
Despite the demonstrated clinical utility of STE for the assessment of LV
remodeling, there are clear factors limiting its clinical adoption.162 Firstly, most clinical
use of STE has been focused on global longitudinal strain despite the availability of
regional measures – significantly narrowing the field of diagnostic information by masking
potentially distinct regional changes.161,163,164 Secondly, obtained strain measurements are
highly dependent on hemodynamics (e.g. blood pressure, heart rate) and assumptions used
to calculate LV wall geometry.165,166 Not fully accounting for these factors diminishes the
value of serial STE-based measurements and inter-subject comparisons.
The objective of the current study is to minimize the load-dependency of STEbased measurements and more effectively leverage the full field of speckle data to assess
LV remodeling. To this end, we integrate STE-derived measures of regional LV geometry
and myocardial strain along with an estimation of the mechanical load (i.e. ventricular
pressure) within an inverse finite-element framework to compute regional passive
myocardial mechanical properties. STE data from porcine models of both ischemia
reperfusion and LV pressure overload are processed in our inverse framework to generate
spatiotemporal maps of a passive myocardial stiffness index and the diastolic myocardial
stress throughout early LV remodeling.
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4.3

MATERIALS AND METHODS

4.3.1 Large Animal Models of HFrEF and HFpEF
For both models of LV failure, mature pigs (Yorkshire, 20-22 kg) were utilized
whereby HFrEF was induced by intracoronary induction of ischemia-reperfusion while
HFpEF was induced by LV pressure overload due to progressive ascending aortic
stenosis.73,109 Briefly, for the HFrEF protocol, the pigs (n=8) were anesthetized (isoflurane,
3%/1.5L/min; nitrous oxide, 0.5L/min) and an angioplasty balloon catheter (5F Launcher
guiding catheter, 0.058-in. HIS, Medtronic, Minneapolis, MN) was placed within the left
anterior descending artery, immediately below the first obtuse marginal branch, under
fluoroscopic guidance (Arcadis Varic C-Arm, Siemens, Munich, DE). After 90 minutes of
coronary occlusion, the balloon was deflated and the catheter system was removed. This
approach resulted in a reproducible apical anterior myocardial infarction, and over time a
reduction in LV ejection fraction (LVEF) – thus recapitulating the HFrEF phenotype.73,122
For HFpEF induced by LV pressure overload, pigs (n=9) were anesthetized as described
above, and the ascending aorta accessed through a left thoracotomy. An inflatable silastic
vascular cuff (12mm, Access Technologies, Skokie, IL) was secured around the
supracoronary ascending aorta and connected to a subcutaneous access port. Serial
hydraulic-mediated cuff inflation was initiated following a one-week recovery period, in
which the cuff was inflated through the access port (via 0.45 mL glycerol) to achieve a
specific target gradient of 75 mmHg across the cuff and induce LV pressure overload. At
weekly intervals thereafter, the cuff was further inflated (0.25 mL increments) to cause a
stepwise increase in the pressure gradient (25 mmHg increase/inflation).
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All animals were treated and cared for in accordance with the National Institutes of
Health Guide for the Care and Use of Laboratory Animals (Eighth Edition. Washington,
DC: 2011) and all experimental protocols were approved by Institutional Animal Care and
Use Committees at the University of South Carolina.
4.3.2 Serial Echocardiographic Studies
The day before animals underwent either coronary occlusion or placement of the
aortic cuff, the pigs were sedated (diazepam, 200 mg), placed in a custom-designed sling,
and transthoracic echocardiographic studies were performed (GE Vivid E9 with XDclear
Ultrasound System; M5S (3.3 MHz, 40 FPS) transthoracic probe). Two-dimensional
echocardiographic cine loops were acquired from a transthoracic right parasternal
approach. The left atrium (LA) and LV were imaged in both the short- and long-axis views.
Pulse-wave and tissue Doppler studies were performed to determine flow velocities and
pressure gradients.167
The pigs were then returned to the laboratory for follow-up imaging studies
under identical conditions and approaches, whereby the HFrEF pigs were returned for
imaging studies at 14 and 28 days post-coronary occlusion and the HFpEF pigs were
returned to the laboratory at 7, 14, 21, and 28 days for both imaging studies and serial
hydraulic-mediated expansion of the aortic cuff under echocardiographic guidance and
sterile conditions as described previously.109
4.3.3 Post-Acquisition Analysis of LV Function and Geometry
The digital echocardiographic images were transferred to a workstation for offline
analysis (EchoPac, Vingmed, GE). LV end-diastolic volume (EDV) and LVEF were
calculated using the biplane method of disks. LA area was determined from the
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anteroposterior dimensions acquired from the parasternal long axis view. For each digital
loop, a region of interest (ROI) was defined at the onset of the R-wave by manually
identifying the endocardial and epicardial borders. The ROI was then discretized with a
spatial mesh of acoustic clusters to be tracked on a frame-to-frame basis throughout a single
cardiac cycle.7 Quantitative strain analysis (Q-analysis) was performed, regional tracking
quality was assessed, and the ROI was manually adjusted by the operator to improve
tracking quality where necessary. Successful tracking of the ROI allowed for the definition
of segmental lengths which were computed at end-diastole (L0) and continuously
throughout the cardiac cycle (L). Segmental strains (𝜀) were then computed as:
𝜀=

𝐿−𝐿0
𝐿0

=

∆𝐿
𝐿0

,

(4.1)

where the reference length refers to the end-to-end length in the longitudinal direction of a
particular echocardiographic segment (i.e. basal posterior, mid posterior, apical posterior,
apical anterior septum, mid anterior septum, or basal anterior septum) or, in the case of
global longitudinal strain, the end-to-end length of the mid-myocardium in the longitudinal
direction (i.e. from the basal posterior, to the apex, and then to the basal anterior septum).
Subsequently, spatial coordinates of the mid-myocardial nodes were exported for each
frame of the digital loop. Additionally, wall thickness was collected at early- and enddiastole for each of the six conventional echocardiographic segments. Pulmonary capillary
wedge pressure (PCWP) was subsequently calculated using the method proposed by
Nagueh et al in 1997.168
4.3.4 Formulation of the Finite-Element Mesh
The initial, unloaded, LV configuration was generated from the position of the midmyocardial nodes at the onset of diastole, the point at which the cross-sectional area was
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at a minimum. For each mid-myocardial node, a thickness was defined by computing a
cubic spline interpolation between the known thicknesses at the onset of diastole of the six
echocardiographic segments. Endocardial and epicardial nodes were subsequently
generated based on the position of the mid-myocardial nodes and estimated thicknesses.
The finite-element mesh was constructed from this reference geometry composed of a
monolayer of eight-node trilinear hexahedral elements with two elements spanning the
distance between each of the mid-myocardial nodes and eight elements spanning the
distance between the pairs of endocardial and epicardial nodes (Figure 4.1A-C). This
process was also completed for the end-diastolic configuration to enable calculation of the
objective function as detailed below (Figure 4.1D-F).
4.3.5 Material Model and Boundary Conditions
The LV myocardium was modeled as a transversely isotropic Mooney-Rivlin solid,
a model well-suited for biological soft tissues with a preferred fiber direction.169 The
uncoupled strain energy function is:
𝐾

𝑊 = 𝐹1 (𝐼̃1 , 𝐼̃2 ) + 𝐹2 (𝜆̃) + 2 [ln(𝐽)]2,

(4.2)

where 𝐾 is the bulk modulus-like penalty parameter and 𝐽 is the determinant of the
deformation gradient tensor. The function 𝐹1 (𝐼̃1 , 𝐼̃2 ), a function of the first and second
invariants of the deviatoric right Cauchy-Green deformation tensor, represents the material
response of the isotropic Mooney-Rivlin ground substance matrix of the form:
𝐾

𝐹1 (𝐼̃1 , 𝐼̃2 ) = 𝑆[𝐶1 (𝐼̃1 − 3)] + 𝑆[𝐶2 (𝐼̃2 − 3)] + 2 [ln(𝐽)]2
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(4.3)

where 𝐶1 and 𝐶2 are the material coefficients and 𝑆 is the regional stiffness index. 𝐹2 (𝜆̃),
a function of the fiber stretch ratio, represents the contribution from the fiber family with
a strain energy of the following form:
0
𝜆̃ ≤ 1
−𝐶
𝐹2 (𝜆̃) = {𝐶3 [𝑒 4 (𝐸𝑖(𝐶4 𝜆̃) − 𝐸𝑖(𝐶4 )) − ln 𝜆̃] 1 < 𝜆̃ < 𝜆𝑚
𝐶5 (𝜆̃ − 1) + 𝐶6 ln 𝜆̃
𝜆̃ ≥ 𝜆𝑚

(4.4)

where 𝐶3 scales the exponential term, 𝐶4 is the fiber crimping coefficient, 𝐶5 is the modulus
of the straightened fibers, and 𝜆𝑚 is the stretch at which the fibers are straightened.
Furthermore, 𝐸𝑖(∙) is the exponential integral function and 𝐶6 is determined from stress
continuity requirements. The fiber orientation was specified for each element to be 15º
relative to the longitudinal axis on the longitudinal-radial plane with a 𝜆𝑚 of 1.10. The
remaining material parameters, barring the regional stiffness index, were valued in
accordance with prior work on biaxial testing on excised canine hearts.17 The regional
stiffness index, 𝑆, was determined from the optimization scheme described in the following
section.
Two quasi-static structural mechanics steps were defined as follows. In step one, a
prescribed translation was applied to the basal nodes from the undeformed configuration
to the expected position at end-diastole as determined from STE. In step two, the basal
node positions were fixed, and the end-diastolic pressure was applied to the endocardial
surface.170 To mimic the tethering effects of the right ventricle and the pericardium, an
opposing pressure was applied to the basal and mid-ventricular epicardial nodes with a
magnitude of 25% of that of the intraventricular pressure.171,172 The solution was computed
using the PARDISO linear solver within the FEBio application.173,174
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4.3.6

Identification of Material Properties
An objective function (𝛱) of the form:
𝛱=(

𝐴′−𝐴
𝐴

𝜀𝑖′ −𝜀𝑖

+ ∑6𝑖=1 (

𝜀𝑖

)+

̅ −𝑡̅
𝑡′
)×
𝑡̅

100% (4.5)

was developed as a function of the actual end-diastolic area (𝐴), regional strain (𝜀𝑖 ) relative
to the undeformed mesh, and mean wall thickness (𝑡̅) determined from the end-diastolic
̅ represent the end-diastolic area, regional
mesh (Figure 4.1F). Additionally, 𝐴′, 𝜀𝑖′ , and 𝑡′
strain relative to the undeformed mesh, and mean wall thickness computed from the
deformed FE model, respectively. The factors entering the optimization scheme were the
stiffness indices (𝑆) defined at the center of each of the six conventional anatomical
segments of the LV. A cubic spline interpolation was used to define a continuous
distribution of stiffness indices between the six segments. A pattern search optimization
algorithm, ideal for the minimization of a non-differentiable objective function, was
employed to identify an optimal set of stiffness indices coincident with the global minimum
of the objective function. The pattern search algorithm was terminated when a successful
poll resulted in a change in the objective function of less than 1E-6 (Figure 4.2).
The optimization process was conducted on a workstation with an eight-core
processor (3.7 GHz) and 32 GB of RAM. After optimization was complete, a final
simulation with a refined FE mesh and assigned regional values of S was performed, thus
facilitating the calculation of the first principal stress field.
4.3.7 Statistical Analysis
Data are reported as the mean ± standard error of the mean. Comparative analyses
between the two groups were performed using a two-way analysis of variance followed by
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pair-wise comparisons using the least significant difference post hoc study. A Pearson
correlation analysis was used to interrelate classical echocardiographic indices with those
derived from regional inverse analyses. A p-value of less than 0.05 was considered
statistically significant. All statistical analyses were performed in MATLAB (version
R2018a, The MathWorks Inc).

4.4

RESULTS

4.4.1

Left Ventricular Function and Geometry
LV function and geometry at baseline and at the two specified time points (14 and

28 days) are shown in Table 4.1. In the HFrEF group, LVEF was reduced and LV dilation
occurred; consistent with the HFrEF phenotype. In the HFpEF group, LVEF and LV
volume were unchanged, whereas LA area increased; consistent with the HFpEF
phenotype. Spatial mapping of regional LV longitudinal strain showed an overall reduction
in the HFrEF group, with the greatest reductions occurring in the mid- and apical-anterior
regions. In marked contrast, regional LV longitudinal strain remained comparatively
preserved in the HFpEF group (Figure 4.3A). Global LV longitudinal strain fell by
approximately 50% from baseline at both 14 and 28 days in the HFrEF group, whereas
there was no change in the HFpEF group (Figure 4.3B). The relative heterogeneity of LV
strain, reflected by the coefficient of variation among regional strains, more than doubled
in the HFrEF group by 28 days but remained unchanged in the HFpEF group
(Figure 4.3B).
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4.4.2 Inverse Estimation of Regional Stiffness Indices
For each case, the pattern search optimization algorithm was initiated, and the
relative error in regional strain, mean wall thickness, and LV area was quantified through
the objective function (𝛱) for each set of stiffness indices defined by the algorithm. A
global minimum of the objective function was reached through iterative refinement of the
stiffness indices for all cases with an average convergence time of 48.6±3.4 minutes. The
minimum objective function values obtained for the HFrEF group at both 14 days and 28
days were found to be significantly elevated relative to baseline values (𝛱=11.8±1.4
(baseline) vs. 𝛱=28.3±7.7 (14 days) and 𝛱=35.3±6.9 (28 days), p<0.05). In contrast,
insignificant changes in the obtained minimum objective function values were observed in
the HFpEF group between baseline and 28 days. Elevated objective function values in the
HFrEF group are an expected consequence of the increasingly heterogeneous wall
geometry and mechanical behavior associated with the induced LV remodeling.
Changes in myocardial passive stiffness of the HFrEF group exhibited obvious
regional dependence, exemplified at 28 days by the nearly order-of-magnitude higher
stiffness index in the infarcted apical anterior region as compared to the remote
myocardium (80.6±14.9 vs. 8.6±2.7) (Figure 4.4A). The global stiffness index, defined as
the spatial-average of the passive regional stiffness indices, reached a maximum at 14 days
in the HFrEF group and remained elevated relative to baseline at 28 days (Figure 4.4B).
While changes in the global stiffness index in the HFpEF group were attenuated in
comparison to the HFrEF group, a greater than three-fold increased relative to baseline was
observed at 28 days. The relative heterogeneity of stiffness, taken as the coefficient of
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variation among regional stiffness indices, was significantly elevated in the HFrEF group
relative to both baseline and the HFpEF group at both 14 and 28 days (Figure 4.4B).
4.4.3 Myocardial Wall Stress
Subsequent simulations that incorporate the identified local stiffness indices
allowed for quantification of the 1st principal stress field at end-diastole. At both 14 and 28
days, the maximal regional stress observed in the HFrEF group was coincident with the
location of the ischemic injury, while a qualitatively more uniform stress distribution was
observed in the HFpEF group (Figure 4.5A). The global 1st principal stress, defined as the
spatial-average of 1st principal stress, was elevated relative to baseline in both groups at 14
and 28 days, with significantly higher stresses in the HFrEF group compared to the HFpEF
group (Figure 4.5B).
4.4.4 Correlation Analysis
A correlation matrix was developed for each group to relate established indices of
global function and geometry to computed biomechanical indices (Figure 4.6). In the
HFrEF group, global LV longitudinal strain positively correlated with LVEF and
negatively correlated with LV volume and LA area. Inverse relations were observed when
these indices were correlated with global stiffness index and global 1st principal stress.
Conversely in the HFpEF group, there was no correlation between global LV longitudinal
strain and LV ejection fraction, volume, or LA area. Notably, LA area, an index of
progressive HF, exhibited strong positive correlations with the computed global stiffness
index and global 1st principal stress in both the HFrEF and HFpEF groups.
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4.5

DISCUSSION
The structural and functional milestones for the development and progression to

heart failure (HF) are changes in LV structure and function – commonly termed myocardial
remodeling. This process is manifested at the regional myocardial level, and thus,
approaches which can identify and be sensitive to changes in regional myocardial
mechanics would allow for early detection in patients at risk for HF progression. While
past studies using magnetic resonance imaging and post-processing algorithms have
identified the potential relevance of assessing regional mechanics in patients with
developing HF, this approach can be problematic. Firstly, this imaging approach is not
amenable to point-of-care application and analysis. Secondly, this imaging approach is not
readily amenable to repeated, serial measurements in terms of screening and identifying
HF progression. Accordingly, the major significance of this study was to put-to-practice a
methodology and framework to quantify myocardial mechanical properties based on postprocessing of typically available echocardiographic data.
While HF is a term which applies to the spectrum of symptoms, it is important to
phenotype the underlying HF process. In that regard, it is now recognized by consensus
that HFrEF and HFpEF are two distinct phenotypes, with differing etiologies, trajectories
to HF, and, most importantly, distinctly different forms of LV dysfunction. To that end, we
developed a novel approach to quantify myocardial mechanical properties and applied it to
relevant large animal models of HFrEF and HFpEF. Our results demonstrated the utility of
this approach in terms of serial measurements and revealed distinctly different patterns of
regional myocardial mechanical changes in HFrEF and HFpEF. This work underscores the
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need for sensitive assessments of LV regional mechanical performance to identify the
development and progression of these HF phenotypes.
4.5.1 Building Upon Prior Studies
Even though the present study developed a regional LV stiffness index which is
unique to this study, relative comparisons to other studies can be made. Specifically,
elevations in the LV stiffness index with HFrEF, which peaked at 14 days post-MI, reflect
similar trends in mechanical property indices reported in both in-vivo and ex-vivo
studies.57,76,79,81,122,175 Furthermore, the more progressive increases in this LV stiffness
index with HFpEF is in agreement with observations made in both small and large animal
models of LV pressure overload-induced hypertrophy.18,132,133,176 However, it should be
emphasized that the increased LV stiffness index in both HFrEF and HFpEF does not imply
similar biological or physiological underpinnings. Specifically, in HFrEF secondary to MI,
the predominant contribution to the increased global LV stiffness index was contained
within the MI regions; reflective of scar formation and collagen accumulation. Contrarily
in HFpEF, the LV stiffness index was due to a more global shift; reflective of the more
diffuse collagen accumulation (i.e. fibrosis). The present study demonstrated that these
distinctly different patterns of LV myocardial stiffness could be identified in both a spatial
and temporal fashion.
4.5.2 Clinical Translation
The approaches applied to these preclinical large-animal models was then put-topractice in terms of deployment as a complete software application (Figure 4.7A) using a
de-identified transthoracic echocardiographic study (privacy policies set forth by the
Department of Veteran’s Affairs Cooperative Studies) of a patient with defined HFpEF
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(i.e. elevated LV filling pressure and LA enlargement). Using the methodological
approaches described herein, the heterogeneous distribution of stiffness indices and
1st principal Cauchy stress was computed (Figure 4.7B-D). As presented, this technology
can be directly translated into a clinical setting as a complement to current standard-of-care
echocardiography studies.
4.5.3 Future Directions
While this proof-of-concept study was completed on a workstation as a postprocessing step for previously acquired images, it is feasible to translate this methodology
to a server or cloud-computing framework to allow for direct incorporation into standard
echocardiography machines. The FE solver and optimization algorithm employed in this
study utilize parallelization of computational cores. Therefore, incorporating this
framework into a many-threaded computational platform will drastically improve
computational time – increasing the likelihood of translating this analysis in a clinical
setting.162 Furthermore, it is reasonable to assume an evolution of this technology which
bypasses the inverse FE optimization all-together. Once this technology has been applied
to enough cases, there will be a large library of evidence detailing the dynamic interplay
between regional passive mechanical property changes and various forms of heart disease.
A future evolution of this technology could be developed as a form of artificial intelligence
informed by a supervised machine learning algorithm to predict the evolution of regional
myocardial stiffness and stresses for a given patient based on the body of evidence
previously collected from other patients.
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4.5.4

Methodological Limitations
The present study demonstrates that an inverse methodology can be reasonably

performed to estimate the passive mechanical properties of the LV myocardium relevant
to a clinical context. However, several methodological limitations must be considered.
First, while our results are in qualitative agreement with previously reported findings, invivo quantification of mechanical properties should be validated against results obtained
from ex-vivo mechanical testing and modeling. Furthermore, given the inherent mechanical
nonlinearity of the myocardium, the resultant passive stiffness indices refer only to a
specific (low pressure) component of the overall myocardial mechanical response.
Additionally, prior studies have shown shifts in the predominant collagen fiber orientation
and undulation as a consequence of disease progression and relative position in the
LV.34,177 While this study assumes a constant fiber angle on the longitudinal-radial plane
and a constant degree of fiber undulation, future iterations of the model will incorporate
these known variations. Finally, the model is limited to two-dimensions and exhibits
sensitivity to the applied boundary conditions. Future work will be focused on translating
this framework to three-dimensions and the application of increasingly realistic boundary
conditions.
4.5.5

Conclusion
The methods and framework proposed herein promote passive myocardial

mechanical property identification, and therefore could help evaluate the rate and extent of
LV remodeling in the context of heart disease. This type of noninvasive, point-of-care
analysis has the potential to significantly improve cardiovascular disease diagnostics and
inform clinicians and researchers on patient-specific disease progression.
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4.7

TABLES

Table 4.1: Echocardiographic estimation of indices of left ventricular geometry
and function

Treatment Day

LVEF (%)

EDV/BW (mL/kg)

LA Area (cm2)

Baseline (17)

0

64.6 ± 1.3

1.6 ± 0.1

6.2 ± 0.3

HFrEF (8)

14
28

37.8 ± 2.3*
37.5 ± 3.4*

2.8 ± 0.2*
2.6 ± 0.2*

10.1 ± 0.4*
11.0 ± 0.4*

HFpEF (9)

14
28

63.8 ± 1.0
66.1 ± 1.0

1.6 ± 0.2
1.5 ± 0.1

9.9 ± 0.5*
11.3 ± 0.5*

Values are means ± SE. * p<0.05 vs. the respective baseline value. (LVEF: left ventricular
ejection fraction; EDV: end diastolic volume; BW: body weight; LA: left atrium)
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4.8

FIGURES

(A)
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(B)

(C)
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(D)

End Diastole
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Figure 4.1: Formulation of the finite element mesh.
(A, D) At both end-systole and end-diastole, quantitative strain analysis was performed
on LV long-axis echocardiographic images. (B, E) Epicardial, mid-myocardial, and
endocardial nodes were defined from the mid-myocardial strain analysis position data
and regional thickness measurements. (C, F) A eight-node trilinear hexahedral FE mesh
was formulated with two elements spanning the distance between each of the midmyocardial nodes and eight elements spanning the distance between the pairs of
endocardial and epicardial nodes
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(A)

(B)

Figure 4.2: Inverse methodology to identify mechanical properties from STE.
(A) From the echocardiographic cine loops, mid-myocardial position data, regional wall
thickness, and estimations of PCWP were acquired. A FE model is generated from the
initial end-systolic geometry and boundary conditions are defined for two quasi-static
simulation steps. An initial guess for the regional stiffness indices is defined and the
converged solution was attained from a PARDISO linear FE solver. (B) The objective
function (𝛱) value is determined and evaluated against the stopping criteria. If stopping
criteria is not met, regional stiffness indices were re-defined from the pattern search
optimization algorithm. After the stopping criteria is satisfied, a final regional
distribution of stiffness indices is acquired, and end-diastolic longitudinal and radial
stress are calculated. The pattern search optimization algorithm iteratively explored
combinations of regional stiffness indices until a minimum value of the objective
function (𝛱) was attained. As the objective function is minimized, the regional strain
computed from the FE model converged upon the experimentally measured regional
strain.
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Figure 4.3: Changes in peak longitudinal strain throughout disease progression.
(A) Spatial maps of the absolute value of the peak LV longitudinal segmental strain
determined directly from quantitative STE were generated for each of the two study
groups at baseline as well as 14 and 28 days after the onset of disease. (B) The global
LV longitudinal strain, taken as the fractional change in the total length of the LV crosssection, was determined for each subject over time. The relative heterogeneity of strain,
taken as the coefficient of variation between each of the regional measurements, was
determined for each subject over time. * p<0.05 vs. respective baseline value; + p<0.05
vs. respective HFpEF value.
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Figure 4.4: Dynamic changes in regional mechanical stiffness throughout disease
progression.
The inverse method of identifying mechanical properties was applied to each subject at
baseline as well as 14 and 28 days after the onset of disease. (A) Representative cases
of both heart disease models demonstrate heterogeneous regional changes in
mechanical stiffness as the disease progresses. (B) The spatially-averaged global
stiffness index was determined for each subject over time. Additionally, the relative
heterogeneity of stiffness, taken as the coefficient of variation for each subject, was
determined for each subject over time. * p<0.05 vs. respective baseline value; + p<0.05
vs. respective HFpEF value.
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Figure 4.5: Determination of end diastolic myocardial wall stress.
The 1st principal stress throughout the myocardium was computed for each subject at
baseline as well as 14 and 28 days after the onset of disease. (A) Representative cases
of both heart disease models demonstrate the spatial variance of 1st principal stress and
the extent to which this is altered throughout the progression of the disease. (B) The
spatial-average of 1st principal stress (i.e. global 1st principal stress) was determined for
each subject over time. * p<0.05 vs. respective baseline value; + p<0.05 vs. respective
HFpEF value.
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Figure 4.6: Correlation between biomechanics and global indices of geometry and
function.
A Pearson correlation was used to interrelate standard echocardiographic response
variables (LVEF, EDV/BW, and LA Area) with patient-matched changes in
biomechanical response variables (GLS, GSI, and Stress) in each disease model.
* p<0.05 for the Pearson correlation coefficient (ρ). (LVEF: left ventricular ejection
fraction; EDV: end-diastolic volume; BW: body weight; LA: left atrium; GLS: global
LV longitudinal strain; GSI: global stiffness index; Stress: spatial-average of 1st
principal stress)
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Clinical Tool
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Figure 4.7: Clinical translation of methodology.
(A) This methodological process was compiled within a novel software application
designed for clinical use and applied on transthoracic echocardiographic images
obtained from a human subject. Quantitative strain analysis was performed, (B) a FE
mesh was generated from the end-systolic geometry, and (C) the inverse method of
identifying mechanical properties was applied to identify a distribution of stiffness
indices. (D) Post-processing of the FE results allows for the calculation of first principal
stress at end-diastole.
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CHAPTER 5
THESIS SUMMARY AND CONCLUSION
5.1

MAJOR CONTRIBUTIONS TO THE FIELD
The seminal principal of biomechanics is the fact that the structure and function of

a given tissue is a consequence of its mechanobiological environment. As the incidence of
heart failure continues to rise along with the aging population in the United States, a
comprehensive understanding of the mechanobiological factors that influence the
progression of the disease will be of vital importance. To that end, we employed a multidisciplinary approach to study the dynamic interplay between myocardial geometry, the
collagen microstructure, mechanical behavior, and mechanical properties in response to
both myocardial infarction and left ventricular pressure overload. The significant and
noteworthy contributions to the field were two-fold. First, we pioneered a non-invasive
approach to quantify the mechanical properties of the LV myocardium using STE. We
accomplished this first through the use of stress-strain relations and a modified thickwalled ellipsoid model. We then improved upon this with an inverse finite element
framework to identify the heterogeneous field of mechanical properties for both large
animal models of heart failure. This work was put to practice in a prospective analysis of a
HFpEF patient after deployment of the methodology into an all-inclusive software
package. Second, in both models of heart failure, we identified potential therapeutic targets.
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Our analysis of the mechanical properties in the post-MI LV (Chapter 2) showed a
significant drop in mechanical stiffness in the non-viable MI region between 14- and 28days post-MI and increases in the stiffness of the viable remote myocardium over that same
period of time. These observations were coincident with increases in end diastolic volume
and LV filling pressure. While it is difficult to discern cause-and-effect relationships
between structural and mechanical changes, these findings underscore the potential
therapeutic benefits of mechanically stabilizing the MI region early in the remodeling
process (e.g. with biomaterial injections). Furthermore, the correlative analysis performed
between microstructural changes and mechanical changes in the pressure-overloaded LV
(Chapter 3) revealed that the reorganization of the microstructure further modulates the
increase in mechanical stiffness late in the remodeling process. Specifically, we observed
a reduction in fiber undulation and preferential orientation in the circumferential direction
that resulted in elevated passive stiffness of the myocardium. Future work focused on
limiting this microstructural reorganization could potentially improve diastolic filling by
restoring the native compliance of the LV.
5.2

FUTURE WORKS
The immediate future of these works is to expand upon the multi-photon SHG

imaging and inverse finite element analysis approach to develop a structure-motivated
platform to identify the constitutive properties of the post-MI LV. We have performed an
initial analysis of the collagen structure in the MI region three (n=3), seven (n=3), 14 (n=4),
and 28 (n=3) days post-MI from a porcine model of left anterior descending artery ligation
along with a cohort of referent control samples (n=3) (Figure 5.1A). Three-dimensional
analysis of the collagen fiber network showed a relative increase in frequency of lower
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values of undulation in all three layers studied as early as three days post-MI. This trend is
shown to peak at 14 days post-MI which coincides with the time at which the infarcted
myocardium has been shown to reach peak passive mechanical stiffness.81,122 Furthermore,
this analysis confirms previously reported claims that collagen fibers become more
circumferentially aligned after MI with the majority of fibers found to be within
approximately 20° of the circumferential axis at 28 days post-MI.34 The azimuthal fiber
angle and undulation in each of the epicardium, mid-myocardium, and endocardium has
been incorporated into a multi-layered finite element model of the two-dimensional LV
(Figure 5.1B). A modification of the framework introduced in Chapter 4 will be applied
to these models so as to allow for the identification of the full set of parameters of the
transversely-isotropic Mooney-Rivlin constitutive model. Furthermore, this analysis will
shed further light on the extent to which the reorganization of the microstructure influences
the passive mechanical properties of the post-MI LV.
Furthermore, while the work presented in Chapter 4 specifically relates to the LV,
the same methodology can be extended to other soft tissues within the body. This extension
would be contingent on two factors: (1) access to an image modality which would allow
for the successful tracking of the tissue deformation in response to a given load and (2) an
accurate estimation of the in-vivo load exerted on the tissue. Candidate applications of
potentially high clinical value include assessment of thoracic or abdominal aortic
aneurysms. First, the irregular geometries of these structures negate the use of analytical
approaches to identify constitutive model parameters and challenge the quantification of
wall stress distributions. Furthermore, STE and magnetic resonance have been previously
applied to track aortic deformation during and after ventricular ejection.178,179 Finally,
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doppler echocardiography can be used to generate a reasonable estimation of aortic
pressure.180 Given the fact that surgical repair of aortic aneurysms carries a mortality rate
approaching 10%,181 this detailed mechanical analysis would provide surgeons with
complimentary data for patient risk stratification and surgical decision making.
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Figure 5.1: Structure-motivated model enables a transient analysis of the
heterogeneous mechanical properties of the post-MI left ventricle.
(A) Regional undulation was computed for the epicardial, mid-myocardial, and
endocardial sections of the MI region. Elevation angle, ϑ, was computed from the
circumferential-longitudinal plane. An angle of ϑ=0° is defined as a fiber perfectly
aligned with the circumferential axis. Azimuthal angle, φ, was computed from the
longitudinal-radial plane. An angle of φ=0º is defined as a fiber perfectly aligned with
the radial axis. (B) Two-dimensional computational models were generated from
echocardiographic images with spatial discretization of the remote myocardium (blue),
border zone (orange), and the MI region (red). Future inverse finite element analysis
will allow for the identification of the full set of parameters of the transversely-isotropic
Mooney-Rivlin constitutive model.
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